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Abstract 
Sepsis is the leading cause of renal failure in critically ill patients, but the pathogenesis 
of septic kidney dysfunction is poorly defined. The current paradigm states that 
hypoperfusion and excessive renal vasoconstriction results in renal ischemia. However, 
experimental data also exist indicating a direct immune-mediated basis of septic renal 
impairment. This thesis aimed to investigate the contribution of both a potent 
vasoconstrictor peptide, endothelin-1 (ET-1), and a receptor that activates the immune 
system in response to a bacterial infection, the Toll-like receptor 4 (TLR4), to the renal 
failure caused by sepsis.  
The first part of this thesis investigated the role of the endothelin system in renal 
microcirculatory and functional impairment caused by experimental septic renal failure, 
by studying the effects of dual endothelin type A and B (ETA/ETB) antagonism and 
selective ETA-antagonism during porcine endotoxemia. ET-1 is a vasoconstrictor 
peptide that is a potent modulator of microcirculatory blood flow. It is released in high 
amounts during sepsis and experimental data have shown that ET-1 reduces renal blood 
flow. In paper I and II pigs were subjected to lipopolysaccharide (LPS) infusion and the 
renal microcirculatory effects of dual ETA/ETB or selective ETA antagonism were 
investigated. The main findings were that dual ETA/ETB blockade attenuated the 
endotoxemia induced reduction in renal cortical microcirculation, as well as the 
increase in plasma creatinine levels (paper I). In addition, selective ETA antagonism 
reduced the decline in renal medullary microcirculation, but had no significant effect on 
diuresis or creatinine clearance (paper II).  
The second part of this thesis investigated the role of TLR4 activation in renal failure 
caused by hyperdynamic endotoxemia or sepsis. Conscious surgically prepared sheep 
were subjected to LPS or live Escherichia coli infusion and observed for 24-36 hours. 
A main finding was that pretreatment with a TLR4-inhibitor attenuated renal failure 
and hypotension caused by endotoxemia in sheep. This effect was greater compared to 
norepinephrine treatment, in a dose that prevented hypotension (paper III). Moreover, it 
was observed that septic renal failure developed without renal hypoperfusion and that 
treatment with a TLR4-inhibitor reversed renal failure when administered 12 hours into 
sepsis (paper IV). This effect was independent of changes in systemic or renal 
hemodynamics but was associated with a reduced renal neutrophil accumulation. 
In conclusion, despite no reduction in renal perfusion or arterial blood pressure, septic 
renal failure may still develop. During hyperdynamic sepsis, stimulation of the innate 
immune system, via TLR4 activation, may contribute to the development of renal 
failure. In addition, TLR4-inhibition is an effective treatment to improve renal function 
in ovine sepsis induced by E.coli. In hypodynamic endotoxemia, ET-1 contributes to 
renal vasoconstriction. By acting on ETA, ET-1 reduces renal medullary blood flow 
causing ischemia but has no short-term effect on renal function.   
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INTRODUCTION 
Acute kidney injury (AKI) is one of the most important forms of organ dysfunction in 
sepsis. Renal failure triggered by sepsis is common and associated with high mortality 
among critically ill patients, despite advanced treatment. This might be related to 
inadequate knowledge of the underlying mechanisms causing septic AKI.  
Reduced renal blood flow and impaired microcirculation resulting in ischemia is often 
considered to be the main basis for septic renal dysfunction, at least when this thesis 
was initiated. This is based on the notion that in sepsis a decrease in cardiac output and 
hypotension results in renal hypoperfusion. Additionally, increased sympathetic nerve 
activity and increased production of vasoconstrictive substances such as angiotensin II 
and ET-1 acts on the renal microcirculation and generates renal vasoconstriction, 
thereby worsening renal ischemia. Infusion of the potent vasoconstrictor peptide, ET-1 
has been shown to reduce renal microcirculatory blood flow experimentally, indicating 
a role in the renal circulation. ET-1 also has inflammatory properties, and increasing 
plasma levels had been correlated to the severity of sepsis in patients. Taken together, 
this gave a theoretical rationale to further investigate the role of the renal 
microcirculation and ET-1 in septic renal failure.  
During the course of this thesis, alternative views on the pathological mechanisms that 
underlie the development of septic AKI gained more attention. The paradigm of renal 
hypoperfusion was challenged by experimental data reporting preserved or even 
increased renal artery blood flow in experimental sepsis, thus suggesting the 
involvement of other mechanism than renal ischemia to septic renal impairment. As a 
result, focus in the second part of this thesis was slightly changed in order to investigate 
direct immune-mediated modulation of renal function. More specifically, the inhibition 
of Toll-like receptor 4 (TLR4) during experimental sepsis was studied.  
The Toll-like receptors recognize specific structures of pathogens. The Toll-like 
receptors recognize specific structures of pathogens and will, upon activation, induce 
an innate immune response through production and release of inflammatory mediators, 
such as cytokines, and stimulation of inflammatory cells 
This thesis is comprised of four papers. It describes in vivo studies performed in two 
separate models of experimental septic renal failure, with the aim to further our 
understanding of the mechanisms underlying kidney dysfunction caused by the 
inflammatory response to a severe infection. 
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BACKGROUND 
THE KIDNEY 
The kidney is responsible for several important functions in the body. It is, for example, 
a vital organ for regulation of water and electrolyte balance, excretion of metabolic 
waste and hormones, regulation of blood pressure and gluconeogenesis. The kidney can 
be divided into two regions: the cortex and the medulla. These two regions are 
structurally and functionally different, and both are essential for the formation of urine. 
The basic unit of the kidney is the nephron, and each kidney contains of approximately 
one million nephrons. These nephrons are built up by a filtering unit called the renal 
corpuscle and a reabsorption unit named the tubules. In the cortex of the kidney, blood 
enters the glomeruli and filtrates over the vessel wall, creating primary urine. The 
filtrate thereafter enters the renal tubules where most of the filtrate is reabsorbed. A 
network of blood vessels surrounds the nephron and recovers the fluid and solutes 
reabsorbed from the different segments. The urine is further concentrated in the 
medulla  (Thomas, 2009;Eaton, 2009).    
The Glomerulus 
A portion of the blood that enters the kidney is filtered under pressure across the 
capillary walls in the glomerulus over the so-called glomerular filtration barrier. This 
barrier is built up by the glomerular endothelial cell surface layer, a fenestrated 
glomerular endothelium, the glomerular basement membrane and the slit-membranes 
between podocytes. The volume of filtrate formed in the glomerulus per unit time is 
known as the glomerular filtration rate (GFR). Under normal physiological condition, 
this value is approximately 180l/day (Eaton, 2009;Patrakka & Tryggvason, 2009). The 
renal microcirculation is essential in the preservation of GFR. 
 
 
 
 
 
 
 
 
Figure 1. Scanning electron microscopy images. On the left, a glomerulus from sheep. The 
blood reaches the glomeruli through the afferent arteriole and enters the capillaries where 
filtration takes place. Podocyte cells, with foot processes, make up the surface of the 
glomerulus. On the right, podocytes and several foot processes lining the glomerular 
capillaries. The podocyte has an elongated cell body, and the foot processes radiate out and 
cover the capillaries in the glomerulus. 
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Microcirculation in the renal cortex 
Autoregulation 
The renal artery enters the kidney and branches to interlobar arteries. These interlobar 
arteries divide up to the arcuate arteries, which branch out to interlobular arteries that 
give rise to afferent arterioles. These afferent arterioles give blood supply to a 
glomerulus in the cortex. After filtration in the glomerulus, the blood continues in the 
efferent arteriole, which branch out and becomes the peritubular capillaries. The 
relationship between the afferent and efferent arterioles facilitates the pressure that 
drives glomerular filtration and the peritubular capillaries built up from efferent 
arterioles surrounds the proximal and distal tubules, and reabsorbs the large amount of 
glomerular filtrate.  In this vascular setting RBF and GFR are highly controlled, mainly 
through autoregulation in the renal cortex. This control occurs in the pre-glomerular 
microcirculation, the afferent arteriole, and is mediated by two mechanisms, the faster 
myogenic mechanism and the slower tubuloglomerular feedback. This is very 
important because autoregulation preserves the regulation of body salt content and fluid 
balance and preserves the glomerular structure. Renal blood flow is very large. The 
kidney is approximately 2% of the body mass and receives as much as 20-25% of the 
cardiac output. This high blood flow is, however, essential to maintain adequate 
filtration of the glomerulus. Renal blood flow is driven by arterial pressure, and 
autoregulation prevents fluctuations when a change in blood pressure occurs. In 
addition, the kidneys’ metabolic rate is a function of renal blood flow, increased blood 
flow will generate more filtration and reabsorption, which is energy demanding (Evans 
et al., 2004). 
The myogenic mechanism  
The underlying mechanism for myogenic control is presumably pressure (probably wall 
tension in the afferent arteriole) and not renal blood flow per se. This myogenic 
response will generate a contraction or a relaxation of the smooth muscle cells in the 
vessel wall to prevent changes in renal blood flow when arterial pressure is altered.  
This myogenic response is very fast and occurs within 0.3-1 second upon stimuli 
(Cupples & Braam, 2007).  
Tubuloglomerular feedback. 
The primary site for this autoregulation of GFR is also the afferent arteriole. The 
structural anatomy of the nephron includes that the distal tubule loops back to the 
glomerulus and the afferent arteriole of the same nephron. This way information of 
tubular fluid content is sensed (Cl- and /or osmolality of the tubular fluid) and can use 
this to regulate GFR and RBF. If the tubular fluid concentration is increased, the 
afferent arteriole will be constricted, and as a result a reduction of GFR will occur. This 
mechanism of vasoconstriction by TGF is suggested to be mediated by adenosine or 
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ATP. The contribution of the TGF mechanism to the renal autoregulation is 
approximately 20-50% (Cupples & Braam, 2007).   
Microcirculation in the renal medulla 
The renal medulla is built up by tubule segment called the loop of Henle, collecting 
duct segments and small blood vessels, vasa recta. The blood supply for the renal 
medulla originates from the efferent arteriole of some juxtamedullary nephrons deep in 
the cortex, but vessels that do not enter any glomerulus, so-called peri-glomerular 
shunts may also contribute to the medullary blood supply. The medullary blood flow is, 
in total approximately 10% of total RBF (Evans et al., 2004). The first part of the 
descending vasa recta (DVR) is similar to arterioles with pericytes and smooth muscle 
in the vessel wall. The DVR change in structure and become more like capillaries but 
with no fenestrations as they descend deeper into the medulla. These vessels will give 
to a small capillary network that builds up the ascending vasa recta (AVR). These AVR 
rise up through the medulla and are characterized by a high degree of fenestrations of 
their vessel wall (Pallone et al., 2003). The medullary blood flow is in part controlled 
by the flow in juxtamedullary efferent arteriole and DVR, but AVR  may also be a site 
for regulation (Pallone et al., 2003). The medullary blood flow is also influenced by 
vasodilatory stimuli from NO and prostaglandins. These mediators have a prominent 
local production within the medulla and supports to maintain a controlled flow of the 
medulla and attenuates the influence of vasoconstrictors such as ANG II and ET-1 
(Evans et al., 2004).   
Renal metabolism  
In the kidney reabsorption of sodium by active pumps, Na/K ATPase, is highly oxygen-
dependent. Approximately 80-90% of the oxygen consumed in the kidney is used by 
mechanisms facilitating reabsorption. This gives a close relationship between oxygen 
consumption and GFR. However, the kidneys’ ability to efficiently use oxygen for 
reabsorption is also an important factor, and both NO and vasoconstrictors such as 
ANG II may influence the efficiency of sodium reabsorption. Large parts of the 
medulla are dependent on oxidative metabolism, making this region susceptible to 
hypoxia. Oxygen delivery to the medulla relies not only on medullary perfusion but 
also on extraction of oxygen in the cortex (Evans et al., 2008). The oxygen delivery to 
the medulla is low and this is in part related to the countercurrent functions of DVR and 
AVR. Oxygen delivered via the DVR diffuses to AVR and is shunted back to the 
cortex. This feature in combination with high oxygen consumption in the process of 
sodium handling makes this region vulnerable for ischemia (Pallone et al., 2003). Large 
amount of glucose from the systemic circulation is filtered and reabsorbed in the 
kidney; but the kidney also plays an important role in the formation of glucose by 
gluconeogenesis. Glucose is produced in the gluconeogenesis from several precursors 
such as lactate, glycerol and amino acids. Glucose metabolism is different in the cortex 
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and medulla. The medulla is mainly fueled by glycolysis, an energy-producing 
metabolic pathway that converts glucose to pyruvate. The cortex is on the other hand 
the major contributor of the energy consuming process that forms glucose out of 
precursors, the gluconeogenesis. This gives a relationship were the cortex is a net 
producer of glucose and the medulla is a consumer and the sum of these processes is a 
net production of glucose in the kidney. The major precursor for gluconeogenesis in the 
human kidney is lactate. Hypoglycemia will increase renal gluconeogenesis by 
increased renal uptake of precursors and thereby increase gluconeogenesis (Mather & 
Pollock, 2011). Based on findings from animal experiment, the removal of lactate 
through renal gluconeogenesis is suggested to be increased during acidosis and the net 
removal of lactate is intact despite severe reductions of renal blood flow (Bellomo, 
2002).  
ACUTE KIDNEY INJURY 
The term acute kidney injury (AKI) is used to describe the full range of renal 
impairment, from small changes to complete organ failure, and the degrees of AKI are 
determined by changes in functional parameters. Two measures of renal function have 
been standardized for defining AKI: changes in serum creatinine level or urine output.  
These variables have been chosen for their ability to identify patients with increased 
risk for an adverse clinical outcomes (death or requirement for renal replacement 
therapy) and not for their ability to accurately detect changes in renal function or 
structural damage in the kidney (Murugan & Kellum, 2011). A consensus definition for 
AKI was suggested from the Acute Dialysis Quality Initiative (ADQI) group in 2005. 
They proposed the RIFLE classification system for grading the severity of AKI. This 
classification is based on relative changes in plasma-creatinine and/or changes in urine 
output (Bellomo et al., 2004). The RIFLE definition and classification of AKI by 
ADQI have been further refined by the Acute Kidney Injury Network (AKIN) (Mehta 
et al., 2007). They recommend that an absolute change in plasma-creatinine (25 µmol/l) 
should be used to indentify AKI among some other adjustment. The definition of AKI 
has been introduced to standardize the research of AKI, both for prevention and 
treatment. The classification of AKI by RIFLE criteria is at present a widely accepted 
system for identifying and staging AKI in the clinical setting as well as in science. 
However both creatinine and urine output are variables that manifest relatively late 
after injury has occurred. Both these systems also use the baseline value of creatinine, 
which is most often not known for patients in the clinical setting, making classification 
difficult in the clinical setting (Ricci et al., 2011a). To overcome some of the 
limitations with creatinine and urine output, incorporation of other biomarkers of AKI 
into these classification systems may be beneficial. The RFILE classification is not 
directly adaptable to the experimental setting, and a classification of AKI to be used in 
animal research is being considered.  
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6 
 
 
 
 
 
 
 
 
 
 
 
 
Sepsis 
The word sepsis has been used for more than 2700 years. One of the earliest references 
are from Homer´s poems, were sepsis was generated from the verb, sepo [σηπω], “I 
rot.” The ancient Greek physician, Hippocrates (460 BC – 370 BC) also made use of 
this term: the word sepidon [σηπεδ´ ων] (“the decay of webs”) can be found in the 
medical collection, Corpus Hippocraticum (Geroulanos & Douka, 2006). Today, sepsis 
is a clinical syndrome defined by the presence of an infection and a systemic 
inflammatory response (Levy et al., 2003). The definitions of sepsis have been 
changing over the years and a recent attempt to make a clear definition was made in 
2001 at the International Sepsis Definitions Conference (Levy et al., 2003). The term 
infection was then defined as a pathological process by the invasion of normally sterile 
tissue or fluid or body cavity by pathogemic or potentially pathogenic microorganisms. 
Defining a Systemic inflammatory response was on the other hand somewhat more 
difficult since no purely biochemical and/or immunological test is available in the 
clinical setting. Therefore a list of possible signs of systemic inflammation in response 
to infection is defined. Some of the signs are: fever, hypothermia, tachypnea, 
tachycardia, leukocytosis/penia, hypotension, increased cardiac output, oliguria and an 
increase in plasma creatinine. The disease is also staged in order of severity; sepsis, 
severe sepsis and septic shock. Severe sepsis refers to when an organ dysfunction has 
developed that worsens sepsis. Septic shock is a state of acute circulatory failure 
characterized by hypotension that persists despite adequate volume resuscitation.  
Sepsis is a very common disease, and the total number of deaths is increasing.  The 
Figure 2. Classification of AKI 
by RIFLE criteria. To meet the 
criteria of each stage 
creatinine or urine output 
criteria need to be fulfilled 
(Mehta et al., 2007).  
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incidence of sepsis has been reported to increase over the past decades and was in 2001 
240 cases per 100,000 based on surveys from the United States (Martin et al., 2003).  
Mortality among patients with sepsis is high, ranging from 20-70% for in-hospital 
mortality, and these patients suffer increased risk of organ failure (Winters et al., 2010). 
The most common sites for infection are the lungs, the abdomen and the urinary tract. 
Among the patients with severe sepsis and septic shock, Gram-negative bacteria are the 
cause in approximately 40% of the cases. E.coli is the most common pathogen among 
the Gram-negative bacteria to cause sepsis (Bochud et al., 2001). 
Sepsis and the kidney 
One of the most important forms of organ dysfunction in sepsis is AKI. Sepsis is the 
major cause of AKI in critically ill patients (Parmar et al., 2009). Though it for a long 
time was considered merely as a result of aggravating sepsis, it is now recognized that 
AKI is an independent risk factor associated with both increased mortality and 
morbidity (Bagshaw et al., 2007;Cruz & Ronco, 2007;Hoste et al., 2006;Joannidis & 
Metnitz, 2005;Levy et al., 1996). It has been suggested that a possible explanation to 
why mortality remains high in septic AKI despite today’s advanced treatment is that the 
pathophysiology of septic AKI is not fully understood (Wan et al., 2008). Current 
pharmacological therapies and technologies are still inadequate for the treatment of 
septic AKI. The treatment of sepsis and septic AKI aims mainly at supporting the 
failing organs and the use of renal replacement therapy, diuretics, and different fluid 
resuscitation protocols are often not sufficient to improve renal function (Ricci et al., 
2011b).  
PATHOPHYSIOLOGY OF SEPTIC AKI 
Current paradigm: hypoperfusion and ischemia  
There are several views on the pathological mechanisms that underlie the development 
of septic AKI. The traditional explanation for renal impairment during sepsis is based 
in part on findings from animal experiment and also from patients. This hypothesis 
suggests that renal hypoperfusion secondary to decreased cardiac output and 
hypotension is important for the development of septic AKI. The renal hypoperfusion 
will eventually lead to ischemia in the susceptible kidney, and acute tubular necrosis 
and apoptosis will develop. Furthermore, increased sympathetic nerve activity, ET-1 
and catecholamine production as well as activation of the renin-angiotensin-aldosterone 
system will be triggered to reduce the systemic arterial vasodilatation. These hormones 
are suggested to even further worsen the vasoconstriction in the renal microcirculation, 
aggravating ischemia (Schrier & Wang, 2004). Endothelial damage in sepsis in 
combination with apoptosis, necrosis and disturbances in the coagulation in the renal 
microcirculation also contribute to the ischemic damage of the kidney. Apoptosis and 
J. Fenhammar 
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necrosis are major mechanisms of cell death that have important roles in ischemic AKI.  
(Schrier & Wang, 2004;Shimamura et al., 1983;Sharfuddin & Molitoris, 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic illustration of pathophysiological mechanism for septic AKI according to 
the current paradigm. This view suggests that increased sympathetic nerve activity and 
vasoactive hormones worsen renal vasoconstriction causing renal salt and water retention 
and subsequently ischemia. 
Alternative concepts 
Renal hyperperfusion 
 In the past years a different view of the pathophysiology in septic AKI has gained 
more focus in the literature. Increased perfusion of the kidney during sepsis has been 
observed in large animal experiments with hyperdynamic sepsis (Langenberg et al., 
2006b). Data from the continuous measurement of renal blood flow in human sepsis is 
however sparse, and the data supporting the hypothesis that renal blood flow is 
increased during sepsis are therefore mainly derived from animal experiments, but there 
are some evidence from human studies (Brenner et al., 1990). An early observation in 
1977 by Ravikant and Lucas showed in a porcine model of sepsis (live bacteria 
Sepsis
Nitric oxide
Vasodilation and 
hypotension
Decreased
cardiac output
Baroreceptor unloading
AKI
Sympathetic nerve activity
Vasopressin
Angiotensin II
Vasoconstriction
causing ischemia
Endothelin 1
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intramuscular injection in the hind-limb) that renal blood flow increased as well as 
medullary blood flow (Ravikant & Lucas, 1977). Some of these results have later been 
reproduced in other large animal experiments, and the concept of increased or 
maintained renal blood flow in sepsis is gaining more attention (Langenberg et al., 
2006b). It is hypothesized that vasodilatation in the renal microcirculation causes a 
reduction in glomerular filtration pressure as GFR, in part, is a function of the 
relationship between the afferent and efferent arterioles. If the afferent arteriole dilates 
and the efferent arteriole dilates even more, RBF will increase, but the pressure within 
the glomerulus will fall and result in a reduced GFR. 
Immune mediated dysfunction 
Septic AKI is suggested by some to be more of a local inflammatory mediated process 
rather than a hemodynamic problem. This hypothesis is in line with a study in critically 
ill patients with severe sepsis, where blood pressure levels did not correlate with the 
severity of AKI (Chawla et al., 2007). The production of cytokines, oxygen radicals 
and infiltration of inflammatory cells may cause direct inflammatory injury to the 
kidney. Systemic inflammation and local renal inflammatory pathways are suggested to 
be combined mechanisms inducing impairment of endothelial and microvascular 
function worsening renal injury (Murugan & Kellum, 2011;Majumdar, 2010;Murugan 
et al., 2010). The role of proinflammatory cytokines in AKI is not well understood, but  
several experimental studies have implicated TNF-α, a pro-inflammatory cytokine, to 
be involved in the development of renal dysfunction in sepsis (Pelte & Chawla, 2009). 
TNF-α injures the kidney directly through specific receptors (TNF-R) and can cause 
glomerular inflammation and tubular damage (Ishikawa et al., 2010). Apoptosis is an 
energy-requiring process of programmed cell death and in experimental septic AKI 
both TNF-α and LPS have shown to result in apoptotic cell death (Pelte & Chawla, 
2009). Apoptosis have also been confirmed to be present in kidney biopsies from 
patients in septic shock combined with capillary leukocyte infiltration (Lerolle et al., 
2010). In addition, invading microbes during sepsis are identified by Toll-like receptors 
and upon stimuli they will initiate production of cytokines and activate inflammatory 
cells. These TLRs have been suggested to participate in the development of renal 
dysfunction in sepsis (El Achkar et al., 2008), but the exact mechanisms were elusive 
prior to this thesis.   
CURRENT TREATMENT OF SEPTIC AKI 
Optimization of hemodynamic variables such as blood pressure and administration of 
fluids is often essential in the critically ill patient with sepsis. In the treatment of sepsis 
the use of drugs with a nephrotoxic effect, such as antibiotics and contrast agents is 
regularly the case in the clinical setting making prevention of AKI of clinical 
importance (Ricci et al., 2011b). The clinical management of sepsis is often based on 
the recommendations from The Surviving Sepsis Campaign, an organization developed 
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to improve the management, diagnosis, and treatment of sepsis. They recommend, 
among several things, that urine output should reach ≥0.5ml/kg/h and mean arterial 
blood pressure should be supported to reach 65mmHg (Dellinger et al., 2008). As fluid 
administration alone often is inadequate to restore optimal hemodynamic stability, 
infusion of vasoactive drugs such as norepinephrine is often used. Norepinephrine 
mediates vasoconstriction via α1-receptors on vascular smooth muscle cells and 
increases heart rate and contractility of the heart via β1-receptors. Loop diuretics, such 
as furosemide, is frequently used in the clinical setting to increase diuresis. Increased 
urine production by loop diuretics is mediated through inhibition of the Na+/K+/Cl− 
pump in the medullary thick ascending loop of Henle. By inhibiting this pump, the loop 
diuretics reduce the reabsorption of NaCl, which leads to more urine. This will also 
give a reduced oxygen demand in the kidney. The use of loop diuretics could therefore 
reduce the effect of ischemia, given that ischemia is involved in the pathophysiology of 
septic AKI. In the clinical setting aggressive fluid resuscitation to restore hemodynamic 
stability may lead to disturbed fluid balance, and loop diuretics can be used to reduce 
this by increasing urine output. If renal function is further reduced, extracorporeal 
blood purification with so-called renal replacement therapy is used as a last resort to 
restore homeostasis. The use of mechanical strategies to reduce fluid overload, correct 
electrolyte disturbance and metabolic disturbances is however more of a support rather 
than a curative measure in the failing kidney, but more advanced technologies are under 
development for removal of endotoxin and inflammatory mediators. Current 
pharmacological therapies and technologies are still inadequate for the treatment of 
AKI in sepsis and especially in septic shock, and mortality remains high (Ricci et al., 
2011b;Ricci et al., 2011a). 
ANIMAL MODELS OF SEPSIS 
Several animal models of sepsis are used in research, and they posses different 
advantages and restrictions. The ideal model would be able to reproduce human sepsis 
in all of its complexity. This model should have similar hemodynamics, inflammatory 
response and show the same histological findings as in human sepsis. The most 
common models include administration of exogenous toxins (e.g. LPS), rupture of the 
animals endogenous barrier to intestinal bacterial flora (e.g., cecal ligation and 
puncture) or administration of live pathogens.  These three types of models are used in 
both small animals (e.g. rodents such as mice and rat) and large animals (e.g. pigs, 
sheep and dogs). The use of large animals has some advantages, such as the possibility 
to perform: repeated blood sampling, extensive hemodynamic monitoring -- both 
systemic and organ-specific -- and to administer continuous infusion of fluids and/or 
therapeutic agents (Doi et al., 2009). The advantage of small animals such as mice is 
the availability of genetically modified animals or knockouts. Knockout mice are  
animals in which a specific gene has been deleted, and have proven useful in studying 
specific mechanisms of disease (Zanotti-Cavazzoni & Goldfarb, 2009). In this thesis 
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we used the LPS model in both pig and sheep (paper I-III). Infusion of live pathogens 
was used in sheep (paper IV). 
Toxin administration 
Models with exogenous toxin administration often use a LPS from Gram-negative 
bacteria such as E.coli. Administration of LPS results in an inflammatory response with 
production and release of cytokines such as TNF-α without the presence of bacteria 
(Michie et al., 1988). However, the use of a single mediator might not reproduce the 
complex immunological responses seen in sepsis caused by viable pathogens. The 
cytokine response in human sepsis is usually less intense, if measured by plasma 
concentration of cytokines. The immune response is also prolonged over time 
compared to endotoxemia in animals (Fink & Heard, 1990a). Endotoxin administration 
does however result in the development of AKI, as indicated by a decline in GFR, 
reduced urine production, increase in blood urea nitrogen and creatinine (Cunningham 
et al., 2004;Doi et al., 2009). The dose of endotoxin can be adjusted from a lethal dose 
to a gradual decline in GFR but with stable hemodynamics. Many small laboratory 
animals, including mice, are relatively resistant to endotoxin, and this model may 
therefore be of limited use for some species. As seen in this thesis, the difference 
between anaesthetized pigs with mechanical ventilation and conscious sheep is 
significant regarding their responsiveness to a similar dose of LPS, paper I-II vs. paper 
III.  
Rupture of the intestines 
Another model often used in experimental sepsis research is cecal ligation and puncture 
(CLP). This model mimics the clinical scenario of sepsis after surgery, such as leakage 
from intestinal anastomoses after bowel surgery. Another example is a patient with a 
ruptured appendix. In the CLP model, the cecum is ligated and the ligated part is 
perforated with a needle. This perforation of the intestinal wall will result in a spread of 
feces with a poly-microbial content into the peritoneum (Buras et al., 2005). This 
model can be adjusted in severity by changing the size and number of perforations in 
the caecum or by increasing the area of ligation. The advantage of this model is that the 
cytokine response is closer to human sepsis compared to endotoxemia. However, with 
the exception of some studies, in this model AKI seldom develops (Doi et al., 2009).  
The poly-microbial flora in this model also makes it more difficult to elucidate the 
specific pathophysiological mechanism involved in the study. However, this model 
with spread of feces with a poly-microbial content into the peritoneum is by many 
considered very useful, because of the hemodynamic response with an early 
hyperdynamic phase as well as the typical cytokine profile (Doi et al., 2009;Buras et 
al., 2005). 
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Infusion of live pathogens 
Bacterial infusion models allow the study of a single pathogen in a controlled 
experiment. These models have been used to study several aspects of sepsis, but of 
particular interest for this thesis is the response in renal hemodynamics and function in 
large animals of sepsis (Doi et al., 2009;Langenberg et al., 2006a;Langenberg et al., 
2007). The dose of bacteria is often high compared to the amount of bacteria found in 
blood cultures in patients, and the infused bacteria usually do not colonize the 
laboratory animal, which is the scenario in the clinical setting. The route of 
administration is commonly intravenous or intra-peritoneal, but administrations into the 
lungs to mimic pneumonia-induced sepsis have also been reported (Buras et al., 2005).   
THE ENDOTHELIN SYSTEM   
The endothelin system was first described in 1988, by Yanagisawa et al. They 
discovered a very potent vasoconstrictor peptide from the culture supernatant of 
endothelial cells isolated from porcine aorta. They named this peptide endothelin  
(Yanagisawa et al., 1988). The endothelins are produced in a variety of tissues 
including the kidney and mediate their function through a group of receptors, so-called 
endothelin receptors. Early after the discovery of the endothelins, a link between LPS 
and endothelin production was reported (Sugiura et al., 1989). Elevated levels of 
endothelins was also demonstrated in septic patients (Weitzberg et al., 1991b) and the 
connection to local effects in the kidney was later suggested (Weitzberg et al., 1991a). 
The endothelins were initially described as modulators of vascular tone, cell 
proliferation and hormone production. Development of specific endothelin receptor 
antagonists has also increased our understanding for the endothelin system and its 
importance in vascular physiology (Levin, 1995). Endothelins are suggested to be 
involved in the development of hypertension, pulmonary disease, renal disease as well 
as numerous other diseases. 
Production 
Three endothelins, ET-1, ET-2 and ET-3 have been found to be encoded by human  
genes in chromosome 6, 1 and 20, respectively (Kawanabe & Nauli, 2011). These 
endothelins are produced by initial synthesis to pre-pro-endothelins, which is reduced 
in number of amino acids by intracellular peptidases to form big-endothelins. In this 
form, big-endothelin is further reduced in amino acids through cleaving by a group of 
enzymes named endothelin converting enzymes to form ET-1. ET-1 is suggested to be 
the most important isoform of the endothelins in the endothelium. In addition, the vast 
majority of studies regarding endothelins have focused on ET-1. The secretion of 
endothelins is maintained by two mechanisms: first, secretion of  granule whit stored 
endothelin and second, constitutive secretion, which is believed to be the most 
important pathway (Khimji & Rockey, 2010). In vascular endothelial cells, production 
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of ET-1 is secreted toward the baso-lateral surface of the cells and acts directly on 
smooth muscle cells in an autocirne/paracrine pathway. Plasma levels of ET-1 is 
therefore much lower than within the tissue (Haynes & Webb, 1994).  Production of 
new ET-1 is the main pathway for regulation of ET-1 levels, since granule secretion is 
of limited importance. The release of ET-1 is stimulated by several mediators such as 
cytokines, angiotensin II, LPS and insulin. ET-1 synthesis is inhibited by several other 
mediators such as NO, ANP, prostaglandin E2 and prostacyklines (Piechota et al., 
2010).  
Endothelin receptors 
ET-1 mediates its effect through a group of G-protein coupled receptors. Two major 
types of receptors have been described, ETA and ETB receptors. The ETA is mainly 
found on smooth muscle cells and ETB primarily on endothelial cells. However, both 
have been localized on a variety of cell types in different organs. In general, ETA 
mediates vasoconstriction and cell proliferation. ETB, on the other hand mediates 
vasodilatation via the release and production of NO and prostaglandins. ETB is also 
suggested to be responsible for the clearance of endothelins from the circulation. 
Results from animal experiments have shown that the vascular endothelium in the 
lungs has a high concentration of ETB and these receptors are suggested to extract 
about 50-70% of plasma ET-1 during pulmonary passage (Dupuis et al., 1996a;Dupuis 
et al., 1996b). When ETB is located on vascular smooth muscle cells the effect can also 
be vasoconstriction (Levin, 1995). When ET-1 binds ETA an intracellular reaction 
occurs which leads to the activation of phospholipase C and the subsequent formation 
of inositol 1,4,5 triphosphate (IP3).  Specific receptors on the endoplasmic reticulum 
are then opened by IP3, and a release of Ca2+ into the cytosol occurs. This elevation in 
intracellular Ca2+ causes cellular contraction by activation of actin–myosin cross-bridge 
cycling, which leads to vasoconstriction. In addition to this increase in Ca2+ ETA 
activation have been seen to induce cell growth and mitogenesis (Simonson & Dunn, 
1990). ET-1 may also through activation of ETB stimulate NO production in 
endothelial cells by activation of endothelial cell NO synthase. Increased NO levels 
will lead to the production of cyclic GMP. This will reduce the intracellular levels of 
Ca2+ as well as activate of protein kinase G. As a result actin–myosin cross-bridge 
cycling is reduced leading to vasodilatation (Ito et al., 2004). 
Endothelin and the kidney 
The endothelin system is a modulator of several mechanisms in the kidney including 
renal blood flow, GFR, reabsorption of water and sodium, and of the kidneys 
contribution to acid-base balance. ET-1 production in the kidney is increased by several 
factors including shear stress, inflammatory mediators, oxidative stress, by the renin-
ANG II system (Kohan et al., 2011). The major isoform of endothelins within the 
human kidney is ET-1, and ET-1 is suggested to mediate most of the renal effects 
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(Karet, 1996). A very high production of ET-1 is localized to the medulla and the 
collecting ducts. The inner medullary collecting ducts produces 10 times more ET-1 
than any other tubular segment in the kidney (Karet, 1996;Kitamura et al., 1989). ET-1 
have however been shown to be produced in a variety of locations within the kidney 
including the endothelial cells lining intrarenal blood vessels, intra-glomerular 
endothelial cells, mesangial cells, podocytes and the tubular epithelium (Neuhofer & 
Pittrow, 2009). In the porcine kidney, both ETA and ETB have been identified in the  
glomerulus, but only ETB is found in papilla preparations (medulla) (Backer et al., 
2001). In comparison, human kidneys show ETA receptors in both the cortex and 
medulla (30% ETA of total number receptors in both medulla and cortex) (Nambi et 
al., 1992). The vascular role of endogenous ET-1 in normal physiology may be to 
primarily act on ETB and mediate vasodilatation in the kidney, but selective ETA-
blockade have shown to increase cortical and medullary blood flow (Evans et al., 
2004;Kohan et al., 2011). On the other hand, exogenous infusion of ET-1, in systemic 
or renal circulation, reduces renal blood flow and GFR (Kohan et al., 2011). ET-1 is 
suggested to constrict the vasculature in the kidney primarily via ETA. This effect is 
seen in larger renal arteries, such as the inter-lobar and arcuate arteries. The 
vasoconstrictive effect of ETA is also seen in the smaller vessels such as the afferent 
and efferent arterioles. The blood flow of descending vasa recta in the medulla have 
also been shown to be reduced by ETA activation within the kidney, in part by 
reducing arteriole diameter in juxtamedullary nephron. In the renal vasculature ETB 
acts on the endothelium to induce vasodilatation. Thus, ET-1 is able to induce both 
vasoconstriction and vasodilatation to regulate the vasculature an modulate renal 
circulation (Neuhofer & Pittrow, 2009). ET-1 can also induce remodeling in podocytes 
(the function of podocytes in the filtration barrier is closely related with their 
morphology, which features interactions of foot processes from adjacent podocytes). 
However, it is unclear if this effect can alter GFR (Kohan et al., 2011). Renal water 
transport is modulated by the endothelin system within the kidney, and especially 
within the collecting duct. Arginine vasopressin (AVP) is an anti-diuretic hormone 
produced in the hypothalamus and secreted into the circulation. The renal effect of 
AVP includes enhanced water permeability in the distal tubule and collecting duct. This 
will result in increased water reabsorption and a subsequent increase in urine 
concentration. The endothelin system modulates this AVP-mediated effect and reduces 
the responsiveness of the collecting duct to AVP. It is suggested that this effect is 
carried out by ETB in the collecting duct, but the exact mechanism remains unclear 
(Edwards et al., 1993;Kohan, 2009). ET-1 may also alter diuresis through the 
modulation of sodium reabsorption. Epithelial sodium channels in the collecting duct of 
the kidney are highly selective ion channels, performing active sodium reabsorption in 
the collecting duct. ET-1 rapidly decreases the opening of the epithelial sodium 
channels in the collecting duct through ETB activation (Bugaj et al., 2008). ET-1 has 
also been suggested to induce an inhibitory effect on Na/K ATPase activity in the 
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medullary collecting duct though ETB. This mechanism is suggested to be in part 
mediated via increased prostaglandin E2 (PGE2) production in the collecting duct 
(Zeidel et al., 1989).   
 
Figure 4. ET receptors in the glomerulus and renal arterioles (A), nephron (B), and vasa 
recta (C). The amount of ET receptor shown in a given area is representative of the level of 
ET receptor activity in that region. Afferent arteriolar smooth muscle has more 
vasoconstrictive ET receptors than do efferent arterioles, while efferent arteriole endothelium 
has more vasodilatory ETB than does afferent arteriole (A). The inner medullary collecting 
duct (IMCD) has the greatest density of natriuretic ET receptors, although natriuretic ET 
receptors exist in the cortical collecting duct (CCD), thick ascending limb (TAL), and proximal 
tubule (PT) (B). Vasa recta express contractile ETA on pericytes and vasodilatory ETB on 
endothelial cells (C). Kohan D E et al. Physiol Rev 2011;91:1-77. Re-produced with 
permission from the American Physiological Society 
Endothelin and the kidney in sepsis 
The endothelin system has been investigated with different antagonists in several 
experimental sepsis studies. These studies have been performed in rodents, dogs and 
pigs. The most common sepsis model is endotoxemia, but CLP and fecal peritonitis (a 
variation of CLP, but instead of rupture of the intestines, feces is simply put inside the 
peritoneal cavity) have also been used. The approaches have been administration of the 
antagonist prior to sepsis, so-called pre-treatment or after the onset of sepsis. The 
results from pre-treatment studies are not univocal. Pre-treatment with a dual ETA/ETB 
antagonist attenuated the rise in creatinine in endotoxemic rats (Ruetten et al., 1996).  
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In another porcine study, pre-treatment with bosentan, also a dual ETA/ETB antagonist 
improved diuresis, without any effect on renal artery blood flow (Weitzberg et al., 
1996). In contrast, another porcine study reported that  pre-treatment with a dual 
ETA/ETB antagonist in combination with diclofenac (a non-steroidal anti-
inflammatory drug that inhibits prostaglandin synthesis by inhibition of 
cyclooxygenase) improved renal artery blood flow but not diuresis (Wanecek et al., 
1997). Positive renal effects with improved renal artery blood flow, urine output and 
creatinine have been reported in endotoxemic dogs pre-treated with another dual 
ETA/ETB antagonist, TAK-004 (Mitaka et al., 1999). Pre-treatment with selective 
ETA or ETB antagonists report no effect on renal artery blood flow or creatinine levels 
in some rodent studies (Ruetten & Thiemermann, 1996;Gardiner et al., 2001), but 
reduced creatinine was observed in another (Albertini et al., 2003). In contrast, rats pre-
treated with selective ETB or dual ETA/ETB antagonists reduced total renal blood flow 
and cortical microcirculation, but no effect was seen on GFR (Nitescu et al., 2008). In 
summary, pre-treatment with selective or dual ETA/ETB antagonists in 
sepsis/endotoxemia report conflicting renal effects, but results from evaluation of renal 
microcirculation is sparse. There are a few studies that administer the ET-antagonists 
after the onset of experimental sepsis, and these effects are also diverse. In a porcine 
endotoxemia study, dual ETA/ETB antagonism did not show any effect on renal artery 
blood flow (Oldner et al., 1998), but renal blood flow (microsphere technique) and 
GFR increased in another porcine endotoxemic study (Chin et al., 2002). In addition, a 
porcine study reported some effect on renal cortical blood flow in fecal peritonitis, but 
this effect was abolished after resuscitation (Krejci et al., 2003). Dual ETA/ETB 
antagonism have recently reported reduced renal inflammation after sepsis induced by 
CLP in rats (He et al., 2006). The effects of endothelin receptor antagonists in 
experimental sepsis are not clear, and contradictory effects on renal hemodynamics 
have been reported. Prior to the work of this thesis, conflicting results about renal artery 
blood flow was reported (Chin et al., 2002;Weitzberg et al., 1996;Wanecek et al., 
1997;Mitaka et al., 1999;Oldner et al., 1998;Ruetten & Thiemermann, 1996;Gardiner 
et al., 2001) which urged further studies, especially on the renal microcirculatory level 
(paper I). During the work with this thesis (paper II), the effect of selective endothelin 
antagonists on renal microcirculation have been reported in pre-treated rats (Nitescu et 
al., 2008), and in a porcine model with treatment after the onset of fecal peritonitis 
(Krejci et al., 2003).  
TOLL-LIKE RECEPTORS 
The discovery of the Toll-like receptors (TLR) introduced a new link between several 
pathogens and the actions of the immune system. The first mammalian TLR to be 
discovered was the Toll-like receptor 4 (TLR4). The recognition of LPS was linked to 
TLR4, and further studies revealed more information of this signaling pathway 
(Poltorak et al., 1998a;Qureshi et al., 1999a;Hoshino et al., 1999a).  This family of 
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receptors was first described in the drosophila as important genes in the embryonic 
development of the fly. The discovery of these signaling pathways and their regulation 
has increased our understanding of sepsis. Toll-like receptors act as pattern recognition 
receptors for a range of molecules, such as bacterial components, fungi, viral 
components but also for host specific molecules. Their response includes the activation 
of immune cells  and production of inflammatory substances (e.g. cytokines) (Takeda 
& Akira, 2007). Until present date, 10 members of the Toll-like receptor family have 
been identified in humans, but up to 13 in other species. The Toll-like receptor family 
in humans can be divided into two groups depending on their location. The first group 
TLR1, TLR2, TLR4, TLR5 and TLR6 is located on the cell surface for detection of 
microbial cell wall components. The other group is TLR3, TLR7, TLR8 and TLR9 and 
they are located within the cell in vesicles. This intra-cellular group mainly recognizes 
microbial nucleic acids (Kawai & Akira, 2010). 
Figure 5. Gram-positive and Gram-negative bacteria are recognized by overlapping and 
distinct repertoire of TLRs. Gram-positive pathogens express lipoteichoic acid, Gram-
negative pathogens express lipopolysaccharide; common pathogen include peptidoglycan, 
lipoproteins, flagellin, and bacterial DNA. Reproduced with permission from the 
Lancet.(van der & Opal, 2008)  
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Toll-like receptor 4 
The first receptor in this family to be identified in mammalians was the Toll-like 
receptor 4 (TLR4). This receptor was shown to be involved in the recognition of LPS, 
the major component in Gram-negative bacteria (such as E.coli) (Poltorak et al., 
1998b;Hoshino et al., 1999b;Qureshi et al., 1999b). However other molecules, besides 
TLR4 are also necessary for the recognition of LPS. The first step involves the binding 
of LPS to LPS-binding protein. This complex is identified by CD14 (surface protein 
mainly on macrophages and neutrophils), a co-receptor for TLR4. Myeloid 
differentiation 2 (MD-2) has also been identified as a co-receptor for TLR4. MD-2 
forms a complex with TLR4 and enhances the receptor’s responsiveness for LPS. Other 
molecules than LPS have been suggested to act as ligands for TLR4. These molecules 
are often a result of cell death and/or injury. Heat shock proteins and extracellular 
matrix components such as fibronectin, hyaluronic acid, and heparan sulfate have been 
implicated as ligands in TLR4 signaling (Triantafilou et al., 2001). HMGB1 is a pro-
inflammatory mediator in septic shock that is released by inflammation or necrotic cells 
and is recognized by TLR4 (also by other TLRs such as TLR2 and TLR9) (Yang & 
Tracey, 2010;Yang et al., 2010). TLR4 is the main receptor for LPS, but other 
receptors may also be involved in the recognition of this molecule. For example, when 
LPS is transported into the cells after recognition by TLR4, other intracellular 
recognition mechanisms may be important, such as NOD1 receptors (Inohara et al., 
1999). The expression of Toll-like receptors is widespread in several types of cells. 
Inflammatory cells such as monocytes, macrophages, dendritic cells and mast cells 
have all been reported to express different Toll-like receptors (Takeda & Akira, 2007).  
However, TLR4 is expressed not only on circulating immune cells but also within the 
kidney itself, and the expression of renal TLR4 in tubules, glomeruli and peri-tubular 
capillaries are increased after sepsis (El Achkar et al., 2006;Samuelsson et al., 2004).  
Toll-like receptor 4 signaling 
Toll-like receptors are trans-membrane proteins with domains containing leucine-rich 
repeats that mediate the recognition of pathogens. They consist of trans-membrane 
domains and an intra-cellular domain, named the Toll–interleukin 1 (IL-1) receptor 
(TIR) domains. These TIR are required for the downstream intracellular signal 
transduction (Kawai & Akira, 2010). Individual Toll-like receptors activate different 
inflammatory responses. The response from an activated TLR4 includes both a 
cytokine response and an interferon response. These different responses are mediated 
by different adaptor molecules binding the TIR-domain in the intracellular space. TLR4 
uses at least four adaptor molecules in its response. MyD88, the first identified member 
of this TIR family adaptor molecule activates the transcription factor NF-κB and 
mitogen-activated protein kinases (MAPKs) to induce inflammatory cytokine 
production (Akira et al., 2006). TRIF another TIR family adaptor molecule induces a 
pathways for activation of the transcription factors IRF3 and NF-κB as well as 
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induction of type I interferon and inflammatory cytokines. TRAM and TIRAP, TIR 
family adaptor molecules functions as sorting adaptors that recruit TRIF to TLR4 and 
MyD88 to TLR4, respectively. TLR4 binds TIRAP at the plasma membrane; thereafter 
this complex binds MyD88 and starts the initial activation of NF-κB. The TLR4 
receptor complex is moved into the endosome and forms a new complex with TRAM 
and TRIF, instead of TIRAP and MyD88, which starts the TRIF-dependent pathway 
that leads to the late-phase activation of NF-κB. TLR4 activates both the MyD88-
dependent pathway and the TRIF-dependent pathway and activation of both these 
pathways results in the induction of inflammatory cytokines by TLR4 signaling, This 
signaling pathway is specific for TLR4, whereas the other known Toll-like receptors 
need only  to activate one of these pathways to result in an inflammatory response 
(Kawai & Akira, 2010).  
Activation of the Myd88-dependent pathway results in increased production of many 
inflammatory genes for inflammatory mediators and also for co-factors of NF-κB 
subunits, which will induce specific production of cytokines such as IL-6, IL-10 and  
TNF-α but also co-factors that will restrict NF-κB activity (Kawai & Akira, 2010). In 
the other pathway, TRIF activates co-factors that lead to NF-κB activation, through 
mechanisms similar to those of the MyD88-dependent pathway. In addition to NF-κB 
activation, the TRIF-dependent pathway leads to IRF3 activation and interferon-β 
transcription. The TRIF-dependent pathway also inhibits the activation of the MyD88-
dependent pathway (Kawai & Akira, 2010). Toll-like receptor signaling also involves 
other negative-feedback loops, thus preventing overwhelming activation of their 
Figure 6.  TLR4 signaling illustrating MyD88- and TRIF-dependent 
pathways  reproduced with permission (Matsunaga et al., 2011).  
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signaling. These negative-feedback loops acts on several levels and includes splice 
variants of their different adaptor molecules and transcription regulator molecules. 
Alternative splicing is a process by which RNA are reconnected in multiple ways 
during RNA splicing. The resulting different mRNA may be translated into different 
protein isoforms, which can lead to altered activity of the protein.  
TLR4 and the kidney in sepsis 
The kidney is susceptible to infections by bacterial invasion through the urinary tract 
system which could lead to urinary tract infection and following pyelonephritis, but 
also by acute kidney injury caused by sepsis. First renal TLR4 mRNA was discovered 
in human kidneys, and then the full TLR4 receptor was located in the renal tubules of 
the human kidney. TLR4 in renal tissue is found in both renal cortex and medulla, 
predominantly at the tubules and collecting ducts (El Achkar et al., 2008). The 
expression of TLR4 is increased in tubules, glomeruli, and the renal vasculature in 
experimental sepsis. In septic rats CD14, the essential co-factor for LPS binding to 
TLR4, is also increased (El Achkar et al., 2006). In addition, systemic infusion of 
radio-labeled LPS in rats reaches the renal tissue, indicating that uptake of LPS occurs 
within the kidney. However, if this uptake of LPS in renal tissue is TLR4-dependent 
remains unclear, though indications from experimental data suggest such a pathway (El 
Achkar et al., 2008;Musson et al., 1978). This hypothesis, that systemic LPS reach the 
tubule where both TLR4 and CD14 are expressed is supported by experimental 
findings in rodents. LPS is probably filtered in the glomeruli and reabsorbed by 
proximal tubular cells through the apical membrane (El Achkar et al., 2008;Musson et 
al., 1978). The importance of TLRs in mediating septic AKI has been implicated by 
experimental studies, including an important observation in mice with a mutation in 
TLR4 (Cunningham et al., 2004).  These mice shown reduced BUN levels (BUN levels 
are used as an estimation of renal function), renal neutrophil infiltration and renal cell 
apoptosis after LPS injection compared to mice with normal TLR4 (wild-type).The 
investigators then performed a cross-transplantation of kidneys between wild type and 
TLR4 knockout mice. These mice were then subjected to an injection of LPS. When 
TLR4 was present systemically but not in transplanted kidneys, the mice developed 
severe AKI. When TLR4was present only in the transplanted kidney and not 
systemically, less severe AKI developed. However, no observations of systemic 
circulation or renal hemodynamics were performed in these mice.  
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AIMS 
The overall aim of this thesis was to describe the pathogenesis of septic renal failure, 
with special emphasis on the endothelin system and the Toll-like receptor 4.  
  
More specifically, the studies aimed to: 
  
• Establish experimental models for studies of septic renal failure 
• Characterize renal microcirculatory changes in hypo- and hyperdynamic 
experimental sepsis 
• Investigate the role of the endothelin system in causing renal microcirculatory 
and functional impairment in experimental septic renal failure 
• Investigate whether TLR4 activation during experimental sepsis is beneficial or 
detrimental for kidney function and, in case of the latter, treatment with a 
TLR4-inhibitor has favorable effects once renal impairment is already present 
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MATERIALS AND METHODS  
EXPERIMENTAL ANIMALS 
The experiments were conducted in accordance with “The European Convention for 
Protection of Vertebrate Animals used for Experimental and other Scientific Purposes” 
(Council of Europe No 123, Strasbourg 1985). The Regional Ethics Committee for 
Experiments in Animals, Stockholm, Sweden approved the studies in advance.  
 
   Species  Model  Observation time    
Paper I  Pig  LPS  5 hours  Anaesthetized 
Paper II  Pig  LPS  5 hours  Anaesthetized 
Paper III  Sheep  LPS  24 hours  Conscious 
Paper IV  Sheep  Live E.coli   36 hours  Conscious 
The pig  
In this thesis two different species were used, the pig and the sheep. In paper I and II 
we used crossbred (Landrace/Yorkshire/Hampshire) female anaesthetized pigs. Pigs are 
omnivores by nature and share many similarities with humans in their metabolism of 
fat, proteins and glucose. They are very sensitive to stress (Van Zuphen et al., 2006a) 
and are therefore not suitable to be used in conscious models of sepsis. The pig is often 
used in renal research because there are many similarities in both anatomy and 
physiology of the porcine and human kidney (Dalmose et al., 2000). Differences of 
interest include lower urine concentration ability and higher GFR in pigs compared to 
the human kidney (Ibrahim et al., 2006). Diuresis is larger in the pig mainly due to its 
reduced ability to concentrate urine (Hammer & Thein, 2002), and a degree of 
proteinuria is often seen in pig as compared to none in humans (Ibrahim et al., 2006). 
The renal artery and its intrarenal branches also share many similarities with those of 
the human kidney but are not identical to the human kidney. The renal veins in the 
porcine kidney have many anastomoses, and the arrangement of the venous system 
cannot be completely transposed between the species, but the likeness is considered to 
be large. Also the constitution of the collecting duct system and the size of the kidney 
share many similarities between the porcine and human kidney (Dalmose et al., 
2000;Bagetti Filho et al., 2008;Pereira-Sampaio et al., 2004;Sampaio et al., 1998). The 
porcine model used in this thesis was adapted, with slight modifications from previous 
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work by Somell et al, who showed that treatment with tezosentan improved cardiac and 
pulmonary function in endotoxemia (Somell et al., 2007).  
The sheep 
Paper III and IV in this thesis describe conscious experiments performed in crossbred 
ewes. Both the endotoxin and the live E.coli model were used to study renal effects of a 
Toll like receptor 4 antagonist. Sheep are ruminants, and in addition to their stomach 
they have three pro-ventriculi: the rumen, the reticulum and the omasum. Sheep feed 
only on vegetable material, and the process of bacterial fermentation in the rumen is a 
very important step in the digestion and uptake of nutrients. Sheep spend 10-15 hours 
per day on rumination. The main source of energy in the sheep is volatile free fatty 
acids formatted in the rumination by bacterial fermentation. Glucose metabolism is 
therefore of less importance in these animals compared to humans. In addition, the 
normal physiological pH in the sheep is around 7.50. They are by nature calm, which 
makes them suitable to conscious experiments when they have adapted to the 
laboratory environment (Van Zuphen et al., 2006b).  
SURGICAL PREPARATIONS AND PROTOCOLS 
All surgical preparations were performed under general anesthesia. However, insertion 
of intravascular catheters and urinary retention catheters in paper III were performed 
after administration of local anesthesia in conscious animals.     
Paper I and II (porcine endotoxemia) 
Anesthesia 
Anesthesia was initiated by a pre-medication with ketamine hydrochloride (10 mg/kg 
intramuscular injection), midazolam (0.5 mg/kg i.m.), and atropine sulfate (0.05mg/kg 
i.m). This first step of pre-medication was performed with one pig separated from the 
group in a separate boxed area but with visual contact with the other pigs. The 
procedure was performed by injection with an 18 gauge (G) needle connected to an 
extension line and a syringe. The animals were then transported from the housing 
quarters to the laboratory room with their eyes covered to minimize visual stimuli. 
Induction of anesthesia was then performed via one of the veins of the pigs’ ear with 
intravenous administration of propofol (60±20mg). The animals were orally intubated 
and ventilated with oxygen in air (FiO2 0.44) and a PEEP of 4 cm H2O. Ventilation 
was adjusted to reach a PCO2 of 4.7–5.3 kPa at baseline and was kept constant 
throughout the experiment. During surgical preparation and the following experiment, 
anesthesia was maintained with sevoflurane [2.6% endtidal concentration (Et%), 
followed by 1.0 Et% throughout the experiment] and an infusion of fentanyl (10 
mg/kg/h) and midazolam (0.15 mg/kg/h) throughout the experiment. If needed, 
additional doses of fentanyl and midazolam were given. Pancuronium bromide (0.5 
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mg/kg/h) was given for muscle paralysis after control of the depth of anesthesia. The 
urinary bladder was catheterized with a Foley catheter No. 8 for urine collection. A 
separate monitor was used for monitoring of the electrocardiogram and airway gas 
parameters. 
Fluid resuscitation 
During the surgical preparation of paper I and II, a continuous infusion of hydroxyethyl 
starch 130/0.4 60 mg/ml was given at a rate of 10 ml/kg/h to all animals. In paper I, all 
animals received a continuous infusion of saline with glucose 25 mg/ml at a rate of 20 
ml/ kg/h throughout the experiment. In paper II, a continuous infusion of Ringer´s 
Acetate (15 ml/kg/h) and saline with glucose 25 mg/ml (5 ml/ kg/h) was started directly 
after the surgery and kept constant throughout the five-hour experiment. 
Intravascular catheters 
Measurements of MAP and blood sampling were achieved with a single lumen catheter 
inserted into the left carotid artery. Fluid infusions were administered through a triple 
lumen catheter inserted into the left jugular vein. A balloon-tipped pulmonary artery 
catheter was connected to a Vigilance Monitor system and inserted through the right 
jugular vein. The position in the pulmonary artery was decided by pressure guidance on 
a monitor. The pressure transducers used in this thesis were calibrated to atmospheric 
pressure at the level of the right atrium and to 100mmHg using a saline column.  
Measurement of renal macro- and microcirculation, paper I and II 
The animals were positioned in a supine position, and a midline laparotomy was 
performed after control of the depth of anesthesia. An ultrasonic flow probe for 
continuous registration of regional blood flow was placed around the left renal artery 
(size 3 or 4 mm) and connected to a recorder. A laser doppler probe was sutured to the 
surface of the left kidney for measurements of cortical microcirculation.  
Measurements in the medulla were also included in paper II, in addition to the cortex 
probe. A needle laser doppler probe was inserted 10-12 mm into the kidney for 
medullary measurements. Position was confirmed visually by opening the kidney post 
mortem. Calibration was performed according to the manufacturer’s instructions before 
inserting the laser doppler probes. The quality of the laser doppler signal was confirmed 
before closing the abdomen.  
Microdialysis (paper II) 
In paper II, two microdialysis catheters were inserted in the kidney. A small opening of 
the capsule was made with a needle, thereafter one probe was inserted in the cortical 
region of the kidney. The second microdialysis catheter was inserted in a right angle in 
a separate opening of the capsule and placed in the renal medulla. Position was 
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confirmed visually by opening the kidney post mortem. The two probes were 
continuously perfused at a speed of 1µl/min with a standard perfusion solution. A 
stabilization period of 60 minutes was allowed before baseline measurements. Samples 
were collected for 10 minutes at baseline, two and five hours after start of endotoxemia. 
All samples were analyzed immediately on a bench top analyzer. 
Experimental protocols 
Porcine endotoxemia (paper I and II) 
All animals received a continuous infusion of endotoxin (Escherichia coli 
lipopolysaccharide, serotype 0111:B4, 900 000 units/µg endotoxin, Sigma-Aldrich 
Sweden AB, Stockholm, Sweden). Endotoxin infusion was started at 0.3125 µg/kg/h 
and was increased stepwise until reaching 2.5 µg/kg/h after 30 min. The rate was then 
kept constant throughout the experiment (5 hours). 
Figure 7. Schematic illustration of the experimental protocol in paper I. Pigs were surgically 
instrumented and subjected to 5h Escherichia coli (E.coli) lipopolysaccharide (LPS) infusion. 
After 2h of endotoxemia they were randomized to receive a bolus dose followed by a 
continuous infusion of either Tezosentan, a dual ETA/ETB antagonist (n=8), or to serve as 
controls (n=8). 
Paper I Dual Eta/ETB antagonism 
The animals were randomized to receive treatment with tezosentan (n=8) or to serve as 
controls (n=8). After two hours, the animals in the tezosentan group were treated with 
tezosentan 1 mg/kg administered over 10 min and then, a continuous infusion with 
tezosentan 1 mg/kg/h were started. After five hours of endotoxemia, the animals were 
terminated by a lethal dose of sodium pentobarbital injected into a central vein. 
Paper II selective ETA antagonism 
After two hours of endotoxemia animals were randomized to receive treatment with the 
selective ETA antagonist, TBC 3711, 2 mg/kg (n=8) or to serve as controls (n=8). The 
dose of TBC 3711, with no ETB effect, was based on the results from pilot experiments 
described by Andersson in (Andersson et al., 2010). At the end of the experiment, the 
animals were terminated by a lethal dose of sodium pentobarbital injected into a central 
vein. 
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Figure 8. Schematic illustration of the experimental protocol in paper II. Pigs were surgically 
instrumented and subjected to 5h Escherichia coli (E.coli) lipopolysaccharide (LPS) infusion. 
After 2h of endotoxemia they were randomized to receive a bolus dose of the selective 
endothelin receptor type A antagonist TBC 3711 (n=8) or to serve as controls (n=8.) 
Paper III (ovine endotoxemia) 
In view of our findings that anesthesia with isoflurane aggravates the renal impairment 
caused by LPS, conscious animals were used for further investigations in paper III and 
IV (Frithiof et al., 2011). The porcine model previously used by our group was not 
suitable for this purpose since pigs are easily stressed in conscious experiments. Prior to 
the experiments one carotid artery was surgical exteriorized and placed in a cervical 
skin loop that were closed around the artery. This procedure makes the arteries 
accessible for easy cannulation. This surgical procedure was performed under general 
anesthesia with isoflurane (2.1–2.3% end-tidal concentration). Induction of anesthesia 
was made by intravenous sodium thiopental (10 mg/kg). All animals were intubated 
and mechanically ventilated. Post-operative treatment for 2 days with buprenorphine 
(0.002 mg/kg) and benzylpenicillin (20 000 IU/kg)–dihydrostreptomycin (0.0025 g/kg) 
were made routinely to reduce post-operative pain and risk of infection. The animals 
were allowed a recovery period of 7-14 days to allow wound-healing before the 
conscious endotoxemia experiments.  
Paper III Pre-treatment with a TLR4 inhibitor 
The animals were randomized to receive a bolus dose (2 mg/kg), followed by a 
continuous infusion (4 mg/kg/24 h) of either the selective TLR4 inhibitor, TAK-242 (n 
=7), or vehicle (n=7). Randomization was blinded. Endotoxemia was started by 
intravenous infusion of E.coli LPS after the bolus dose of TAK-242 or vehicle. The 
infusion rate was slowly increased during the first 30 min to reach 3µg/kg/h. This rate 
was then maintained for the remainder of the experiment (24 hours). In an additional 
group, LPS was administered as previously described. However, to prevent 
hypotension, norepinephrine was titrated to maintain MAP at baseline levels. Fluid 
volume support was administered as Ringer’s acetate solution at 0.5 ml/kg/h in all three 
groups. In the norepinephrine group, additional volume support was given as bolus 
doses (200–250 ml) of hydroxyethyl starch if MAP did not increase as expected in 
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response to norepinephrine. Blood samples were drawn at baseline and at 6, 12, 18, and 
24 hours after the start of endotoxemia. Urinary output was measured, and urine 
samples were collected every second hour. 
Figure 9. Schematic illustration of the experimental protocol in paper III. Before an 
Escherichia coli (E.coli) lipopolysaccharide (LPS)  infusion  for 24 h, sheep were randomized 
to receive a bolus dose, followed by a continuous infusion,  of either TAK-242 (n= 7) or 
vehicle (n= 7). A third group of LPS-treated sheep (n = 6) received norepinephrine, titrated to 
maintain baseline arterial blood pressure (MAP). In the norepinephrine group, additional 
volume support was given as bolus doses (200 –250 ml) of hydroxyethyl starch if MAP did 
not increase as expected in response to norepinephrine. 
Paper IV (ovine live E.coli infusion) 
In this paper, the animals were subjected to one surgical preparation and were then 
allowed to recover for 12-18 hours before the experiments commenced.  
Anesthesia  
Surgical anesthesia included premedication with acepromazin (0.3 mg/kg), in order to 
reduce stress and discomfort for the animals. Anesthesia was conducted by the same 
protocol as in paper III.  
Intravascular catheters 
A small incision was made and the carotid artery was visualized and cannulated. 
Intravascular catheters were inserted in the jugular veins and a flow-directed 
thermodilution catheter was fed into the pulmonary artery via an introducer in the right 
jugular vein. The position of the catheter was determined by pressure guidance on a 
monitor. All catheters were sutured to the skin and the incision above the carotid artery 
closed. Proper fixation of these catheters was essential for a successful experiment. The 
catheter was secured and positioned in way that discomfort for the animals was 
minimal.  
Measurement of renal macro- and microcirculation, paper IV 
After a flank incision the left kidney was visualized and an ultrasonic flow probe was 
placed around the renal artery. Thereafter a laser Doppler probe (0.25mm fiber 
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separation, 780nm wavelength) was sutured to the surface of the kidney for cortical 
measurements and a needle laser Doppler probe (0.15mm fiber separation, 780nm 
wavelength) was inserted 10-12 mm into the kidney for medullary measurements. Two 
microdialysis catheters (as in paper II) were inserted into the renal cortex and medulla. 
After surgical preparation, the flank incision was carefully closed.  Connecting tubes 
and their connectors placed at a paralumbar position. Postoperative fluid support was 
given of hydroxyethyl starch, 10 ml/kg, iv (130/0.4, 60 mg/ml, Voluven). Peri- and 
postoperative analgesics were administered as buprenorphine (0.002 mg/kg im) and 
fentanyl (1 µg/kg iv). 
Figure 10. Schematic illustration of the experimental protocol in paper IV. Sheep were 
surgically instrumented and subjected to 36h infusion of live E.coli. After 12h of sepsis they 
were randomized to receive a bolus dose followed by a continuous infusion of either TAK-
242, a selective TLR4 inhibitor, (n=7) or vehicle (n=7). 
Paper IV, treatment with a TLR4 inhibitor in manifest septic AKI 
The experiments were performed with conscious animals placed in individual pens with 
access to water and hay ad libitum. A bacterial infusion was started with a bolus 
(3.9⋅109 CFU) followed by an infusion (6.0⋅109 CFU/), starting at a rate of 0.2ml/h. The 
infusion rate was then increased stepwise every 6 hours until reaching 4 ml/h after 30 
hours and then kept constant until the end of the experiment. After 12 hours of sepsis 
sheep were randomized to receive a bolus dose (2 mg/kg) followed by a continuous 
infusion (4 mg/kg/24hours) of either the selective TLR4 inhibitor, TAK-242 (n=7) or 
vehicle (n=7). To exclude that the surgery per se had a major impact on the results 
obtained in the TAK-242 and vehicle groups, an additional sheep served as time-
control. This included surgical preparation, recovery and monitoring for 36 hours, but 
no E.coli infusion or treatment. Fluid volume support was administered as Ringer´s 
Acetate solution iv at 1 ml/kg/h and started six hours before the infusion of live E.coli 
bacteria. After 36 hours of sepsis animals were deeply anaesthetized with sodium 
thiopental and terminated by an overdose of potassium chloride. The kidney was 
rapidly harvested and prepared for histological evaluation. If an animal showed signs of 
great discomfort during the experiment they were anaesthetized with sodium thiopental 
and terminated by an overdose of potassium chloride. This was the case for nine out of 
23 sheep subjected to live E.coli. These animals were euthanized before completion of 
the protocol. Five of these nine animals were euthanized before any treatment was 
started. In addition, between 12 and 14 hours of sepsis two TAK-242 treated animals 
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and two vehicle-treated animals were also euthanized. These nine sheep were not 
included in the data. 
HEMODYNAMIC AND METABOLIC MONITORING 
In all four papers of this thesis hemodynamic recordings were performed. In paper I, II 
and IV carotid artery was surgically visualized and cannulated for measurement of 
arterial pressure. In paper III the carotid artery was put in a skin loop on the neck of the 
sheep for easy access.  From the obtained arterial pressure curve mean arterial pressure 
and heart rate was calculated. The pressure transducers were calibrated to atmospheric 
pressure at the level of the heart and to 100 mmHg or 25 mmHg using a saline column. 
These transducers have a continuously active flush of 3 ml/h. 
Thermodilution 
In paper I-IV of this thesis cardiac output was measured with thermodilution technique. 
A flow-directed thermodilution catheter was fed into the pulmonary artery via an 
introducer in the right jugular vein and the position was determined by pressure 
guidance on a monitor. The pulmonary artery catheter was connected to a Vigilance 
Monitor system where the cardiac output was calculated every 30-60 seconds and core 
temperature was measured continuously. When the body temperature exceeded the 
upper range for automatic measurements (i.e. 41 degrees Celsius), manual cardiac 
output measurements were performed by three consecutive injections (10 ml) of 
isotonic saline. In brief, manual cardiac output measurements were performed as 
follows: 
1. A 10 ml of saline (indicator) with a known temperature was injected into the right 
atrium through the catheter.  
2. The circulation carried the saline through the heart, where it was mixed and 
temperature in the diluted blood lowered. 
3. This diluted blood was carried by the circulation and the temperature was measured 
by the catheter after the heart, in the pulmonary artery. 
4.  These changes generated a time-temperature curve. The area under the curve is 
inversely proportional to cardiac output.  
Some of the known errors from the manual cardiac output measurements are variations 
in temperature of the indicator, variations in volume (i.e. if 9 ml of saline is injected 
instead of 10 ml, resulting in an overestimation of cardiac output) and dead space 
volume of saline within the pulmonary catheter (Reuter et al., 2010). Repeated 
measurements (three injections) were performed to increase reproducibility in the 
manual measurements. The continuous measurements of cardiac output by the 
Vigilance Monitor system also rely on the thermodilution principles. But, instead of 
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injecting cool saline in a bolus, blood in the superior vena cava is heated intermittently 
by an electric filament. The filament is heated for 1 to 4 seconds in a random sequence. 
These measurements are put together into a single thermodilution curve (Yelderman, 
1990;Yelderman et al., 1992). Continuous measurements may have limited accuracy 
during periods of rapid changes in cardiac output, due to time delay (5-15 minutes to 
detect changes in cardiac output from 20-80%) (Reuter et al., 2010).  
Ultrasonic flow probes 
An ultrasonic flow probe was used for the measurement of renal artery blood flow in 
study I, II and IV. The probe was positioned around the left renal artery either after a 
midline laparotomy (paper I and II, size 3 or 4 mm probe) or after a flank incision 
(paper IV, 4 mm probe). The ultrasonic flow probes consist of a probe with an 
ultrasonic transducer and an acoustic reflector. The transducer sends out an ultrasonic 
wave through the vessel (renal artery for this thesis) in the upstream direction, and then 
hits the acoustic reflector. The probe then sends out a wave in the opposite direction 
(down-stream) and hits a reflector. After being received by the transducer the ultrasonic 
waves are converted into electrical signals. From these signals, the flowmeter derives 
an accurate measure of the time for the wave to pass the vessel (transit time). The 
ultrasonic beam is measured at several points, the receiving transducer sum these 
measurements over the renal artery, which can then be calculated to a volume flow. 
Laser Doppler flowmetry 
This technique is used in paper I, II and IV, and gives an estimate of the blood flow in 
the renal microcirculation. The main principle of this technique is the so-called doppler 
effect (Stern, 1985;Stern et al., 1979;Stern et al., 1977). The doppler effect states that a 
wave undergoes a change in frequency when the source of the wave or the observer of 
the wave is moving in position. This effect is sometimes exemplified by the high pitch 
of a siren when an ambulance is moving towards you and the following drop in pitch 
from the siren when the ambulance passes by. The laser doppler probe sends out a ray 
of light (laser), which hits the area of interest, in this thesis the renal cortex or medulla. 
This light will either be absorbed by the renal tissue itself, or scattered after hitting 
moving objects (e.g. red blood cells) or static objects (e.g. renal cells). The scattered 
light from moving objects will undergo a shift in frequency and scattered light from 
static object will not undergo a shift. All reflected light will be recorded by a photo-
detector within the probe and carried out to the main unit. This signal is transformed to 
an estimate of the changes in velocity and often called Flux unit or Perfusion unit. This 
technique does not allow a true measurement of flow but instead an estimate of the 
flow measured in arbitrary units (Stern, 1985). One reason for this is that the volume of 
tissue being reflected is not static (maximum of 1mm3 with the probes used in this 
thesis). The depth of the signal in the tissue is limited by factors such as, the optical 
qualities of the tissue (darker tissue = less depth of the signal) and the distance between 
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sender and receiver in the probe (Stern, 1985;Stern et al., 1979;Stern et al., 1977). To 
reduce variations in measurement each probe is calibrated in a solution with a known 
inherent movement, often called a motility standard. Another limitation of this 
technique is that movement of the laser doppler probe or its base unit also interferes 
with the signal, therefore in paper IV, when the probes are used in conscious animals 
extra care was made for securing the probes to the surface of the kidney. However, any 
movement of the animals will reduce the quality of the laser doppler signal. The 
individual flow in a specific micro-vessel, heterogeneity of the microcirculation or 
number of vessels with active flow cannot be measured with this technique.   
Microdialysis 
The interstitium is defined as the area between the capillary wall and the surrounding 
cells. As the interstitial fluid surrounds the cells, its composition is often interpreted as 
the local metabolic status of the cells. Regional monitoring have the advantage of 
revealing local disturbance that may be difficult to detect in systemic plasma samples. 
We therefore used the microdialysis technique which enables repeated measurements 
of the interstitial fluid. The microdialysis catheter is constructed by a membrane, 
permeable for water and small solutes, such as glucose, lactate and pyruvate. This 
catheter is introduced in the tissue of interest, in this thesis the renal cortex and 
medulla. The catheter is continuously perfused with a fluid that will pass by the 
membrane and then be collected for analysis. When the perfusion fluid reaches the 
membrane a diffusion of molecules between the extra-cellular fluid and the perfusion 
fluid will take place. The perfusion fluid is often called dialysate after this diffusion of 
molecules. The content of the dialysate is then analyzed. This technique gives an 
estimate of the interstitial fluids that surrounds the cells in the tissue of interest. 
However, the collected dialysate will reflect only a fraction of the true concentration in 
Figure 11. Schematic drawing of a 
laser doppler probe.  The source  
sends out a beam of light. Both 
tissue cells and red blood cells will 
reflect the light to the detector. 
Light hitting moving objects will 
undergo a shift in frequency, the 
doppler effect. This signal is 
transformed to an estimate of red 
blood cell velocity.  
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the interstitial fluid.  This proportion is often referred to as the recovery of a substance 
in the dialysate. The recovery of a substance is dependent of several factors including 
flow rate of the perfusion fluid, area of the semi-permeable membrane and temperature. 
The highly vascularized tissue in the kidney increases the risk for bleeding when 
inserting the probes, however only small amounts of blood was seen during the surgical 
preparations in both the pig and sheep model. In addition local damage and necrosis at 
the probe site may have an influence on the measurements. In paper II, a stabilization 
period of 60 minutes was allowed before baseline measurements. The perfusion speed 
was set to 1µl/min and samples were collected for 10 minutes at baseline, 120 and 300 
minutes after start of endotoxemia in anaesthetized pigs.  In paper IV, a recovery period 
of 12-18 hours was allowed before baseline measurements was performed for six hours. 
The perfusion speed was set to 0.3 µl/min. Every sample period was then six hours and 
continued during 36 hours of sepsis in conscious sheep.  
Interventional substances and procedures 
Endotoxin  
LPS from E.coli bacteria was administered intravenously in paper I, II and III to create 
an experimental model of sepsis. LPS is a component of the cell wall of the Gram-
negative bacteria and stimulates the release of inflammatory mediators, such as 
cytokines (Fink & Heard, 1990b). LPS accounts for approximately 70% of the outer 
membrane of Gram-negative bacteria and is essential for cell viability for Gram-
negative bacteria (except for Neisseria meningitides, in which some strains do not 
produce LPS) (Opal & Gluck, 2003). The toxicity of LPS is related to the host response 
to this microbial mediator, because LPS presumably have no toxic properties by itself 
(Beutler & Rietschel, 2003). This model is reproducible and often used in animal 
models, but is not considered to be identical of sepsis in humans (Poli-de-Figueiredo et 
al., 2008). LPS is built up by a polysaccharide antigen (O-antigen) which is connected 
to an oligosaccharide and a glycolipid structure (lipid A). Lipid A is the portion of the 
molecule that LPS is anchored to the cell membrane. The O-antigen is composed of 
repeating oligosaccharide extending out from the bacteria, and this structure and 
composition vary between serotypes of bacteria. This structure can protect the bacteria 
against complement complex and protect from several antibiotics. Lipid A is the region 
of LPS that activate TLR4. The number and the length of lipid A’s fatty acids vary 
among different bacteria. The length of these fatty acids has a major influence on the 
biological activity of lipid A (Banoub et al., 2010).  
Because endotoxin forms micelles and binds to glass surfaces, solutions of endotoxin 
were vortexed for 30 minutes or longer before dilution or direct use. Endotoxins are 
highly heat-stable and resistant to extreme pH values and are not destroyed under 
regular sterilizing conditions. Endotoxin can be inactivated when exposed at 
temperature of 250ºC for more than 30 minutes or 180º C for more than 3 hours. The 
Materials and Methods 
33 
term endotoxin units (EU) describe the biological activity of an endotoxin and make 
comparison between different batches of LPS easier. 
Live Escherichia Coli  
A live E.coli infusion was used in paper IV to induce experimental sepsis. In all 
animals the same strain of bacteria was used. The bacteria in the study were isolated 
from a positive blood culture acquired from a septic patient and identified as E.coli.  
The isolate was sub-cultured in broth in conical bottles and incubated at 30°C over 
night on a rotary shaker. The broth was centrifuged and the pellet was re-suspended in 
phosphate buffered saline. The bacteria were counted, batched in 2⋅1011 colony forming 
unit (CFU) bacteria per tube and frozen at −70 °C for further use. LPS is, as mentioned 
before, a component of the cell wall of the bacteria and continuously released into the 
surroundings. The release does not only occur with cell death but also during growth 
and division of the bacteria. A single E.coli bacterium contains about two million LPS 
molecules. In addition to LPS, E.coli bacteria consist of several products that can be 
recognized by the immune system such as, bacterial DNA which can be recognized by 
TLR9, lipoproteins detected by TLR2, peptidoglycan detected by TLR2 and flagellin 
detected by TLR5, as mentioned in previous chapters. Thus the E.coli bacteria may be 
identified by the immune system through several different TLRs.  
Tezosentan 
Tezosentan is a potent and water soluble endothelin receptor antagonist. This drug has a 
high affinity to ETA receptors, but also to the ETB receptor. The potency against ETA 
over ETB is about 30 times. This is a competitive antagonist with a short half-life, 
about 10 minutes in humans (Clozel et al., 1999). The primary elimination mechanism 
is biliary excretion of unchanged compound. However, some metabolism occur by 
hydroxylation, but the impact of this metabolite is suggested to be low, and no 
accumulation has been reported (Dingemanse et al., 2002). In paper I, animals received 
tezosentan as a bolus injection 1mg/kg followed by a continuous infusion at 1 mg/kg/h. 
The dose of tezosentan was selected in accordance to findings by Chin et al who 
showed beneficial effects on renal function at this dose in neonatal piglets (Chin et al., 
2002). 
TBC 3711 
This drug was used in Paper II due to its high potency and selectivity for ETA over 
ETB (approximately 400000-fold for ETA over ETB). TBC3711 have a half-life of 
about 7 hours in humans. (Wu et al., 2004).  
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Norepinephrine 
In order to explore if any effect of TAK-242 was due to preventing hypotension, a 
group of LPS-treated animals received norepinephrine titrated to maintain baseline 
blood pressure in paper III. Norepinephrine mediates several effects on the circulation. 
Vasoconstriction is mediated via α1-receptors on vascular smooth muscle cells. 
Norepinephrine also increases heart rate and contractility of the heart via Β1-receptors. 
TAK-242 
TAK-242, a cyclohexene derivative, is a small-molecule compound that selectively 
inhibits TLR4 signaling. TAK-242 binds to the intracellular TIR domain of TLR4 and 
by doing so inhibits TLR4 signaling by disrupting the interactions of TLR4 with its 
adaptor molecules As a result NF-κB activation and cytokine gene expression in 
response to LPS are inhibited (Matsunaga et al., 2011).  
Enzyme-linked immunosorbent assay 
In paper I, enzyme-linked immunosorbent assay (ELISA) manufactured kits were used 
for the determination of porcine plasma levels of three cytokines, porcine TNF-a, 
porcine IL-10, and porcine IL-6. All ELISA-kits were specific for the respective 
porcine cytokine. In brief, in each kit antibodies against the respective cytokine was 
pre-coated in wells of a plate. Samples as well as control and standard were put into the 
wells. If the sample contains the cytokine, it is bound to the pre-coated antibody in the 
well. After washing the wells, a monoclonal antibody with an enzyme linked to it is 
added and bounds to the antibody/cytokine complex. After additional wash the 
substrate for the enzyme is added in a solution. The reaction by the enzyme and 
substrate solution will result in a blue product that will change color to yellow when a 
stop-solution is added. The intensity of the color, measured in on a plate-reader, is in 
proportion to the amount of the respective cytokine bound in the initial step of the 
assay. 
Radioimmunoassay  
In paper I, plasma concentrations of aldosterone and angiotensin II were measured by 
radioimmunoassay (RIA) using commercially available kits. In paper I and II of this 
Figure 12. TAK-242 a 
selective TLR4 inhibitor 
interferes with interactions 
between TLR4 and its 
adaptor molecules, TIRAP 
and TRAM. Reproduced with 
permission (Matsunaga et 
al., 2011).  
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thesis, plasma concentrations of ET-1 was also measured by RIA as previously 
described by Hemsen (Hemsen, 1991). In brief, radioimmunoassay is a sensitive 
method for measuring very small amounts of a substance.  
N-acetyl-β-D-glucosaminidase 
N-acetyl-β-D-glucosaminidase (NAG) is a proximal tubular brush border lysosomal 
enzyme, which is released into the urine after renal proximal tubule injury. The 
relatively high molecular weight (140 kDa) prevents filtration of the enzyme by 
glomeruli. Small alterations in the epithelial cells in the brush border of the proximal 
tubules result in release of NAG into the urine and the amount of enzyme have been 
directly correlated to tubular injury. The use of urinary NAG activity as a marker of 
acute and chronic kidney injury was described in 1975 by Wellwood and colleagues 
(Wellwood et al., 1975;Liangos et al., 2007).  
Statistical analysis 
The results are presented as means and standard error of the mean (SEM) for paper I-
III. In paper IV results are presented as means and standard deviation of the mean (SD) 
or as mean and 95% confidence interval. Main effects were analyzed using a two-way 
analysis of variance with time as a repeating variable as within effects and treatment as 
between effects. In paper III the study investigated the effect of three different 
treatments (TAK-242, Vehicle or Norepinephrine) and if the ANOVA resulted in a 
significant main effect, pairwise comparisons were performed. To address the problem 
of multiple comparison Bonferroni correction was used. Transformation of the data was 
performed by taking the logarithm of the raw data, if it did not follow a normal 
distribution.   
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RESULTS AND COMMENTS 
The present thesis is based on four separate papers, of which two are published and two 
are presented in manuscript form. Detailed information about results, methods and 
discussion are found in the respective paper. This section will highlight some specific 
results and in brief put them in perspective.  
ETA/ETB IN PORCINE ENDOTOXEMIA  
Paper I  
The aim in paper I of this thesis was to evaluate the role of ET-1 in endotoxemia. The 
hypothesis was that inhibition of ETA and ETB with tezosentan would attenuate the 
deterioration in renal cortical microcirculatory blood flow. The rationale for this 
hypothesis was that previous experimental results had shown that exogenous 
administration of ET-1 reduced renal cortical blood flow and constricted cortical and 
juxtamedullary arterioles (Denton et al., 2004). In addition to this vascular effect under 
physiological conditions, previous studies had demonstrated beneficial effects of 
tezosentan on total renal blood flow in endotoxemic shock (Chin et al., 2002).  
However, the results of previous studies investigating the effects of endothelin receptor 
blockers where not univocal, as another endothelin receptor blocker, bosentan, had 
shown contradictory effects on renal hemodynamics in animal models of sepsis (Krejci 
et al., 2003;Heyman et al., 2000;Wanecek et al., 1997;Mitaka et al., 1999;Oldner et al., 
1998).  In addition to the renal effects, dual ETA/ETB antagonism had been reported to 
improve cardiac function, reduce pulmonary hypertension, and reduce the 
inflammatory response in animal studies, prior to our investigations (Konrad et al., 
2004;Rossi et al., 2004;Urbanowicz et al., 2004). ET-1 had also been reported to 
induce inflammation by stimulating the release and production of pro-inflammatory 
cytokines and activation of the transcription factor nuclear factor κB (NF-κB), all 
important mediators in the septic inflammatory response (Cunningham et al., 
1997;Browatzki et al., 2000).  
In paper I, animals were randomized to treatment with tezosentan or to serve as control 
and the main finding in this investigation was that treatment with tezosentan attenuated 
the acute reduction of renal artery blood flow as well as the perfusion in the cortical 
microcirculation in response to endotoxemia. In contrast to these results in paper I, 
bosentan, a dual ETA7ETB antagonist with less pronounced ETA affinity over ETB 
compared to tezosentan, had failed to alter renal cortical blood flow during septic shock 
(fecal peritonitis) in pigs (Krejci et al., 2003). Different experimental models (fecal 
peritonitis vs. endotoxemia) as well as differences in pharmacological properties 
between tezosentan and bosentan could account for the discrepancies in effect on the 
renal vasculature. The results from Krejci et al were also difficult to interpret. In their 
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study, bosentan was given after two hours of shock induced by fecal peritonitis, and in 
the control group renal cortical microcirculation was significantly lower compared to 
the bosentan-treated group before any treatment was given. This makes statistical 
interpretation of their renal results difficult (Krejci et al., 2003).  
As the decline in cardiac output was attenuated by tezosentan, one could argue that the 
improved renal artery blood flow and cortical microcirculation seen in Paper I only 
reflects the increase in cardiac output. However, earlier studies including those of 
Krejci and colleagues have failed to demonstrate renal improvements, despite positive 
changes in cardiac output (Krejci et al., 2003;Heyman et al., 2000;Wanecek et al., 
1997;Mitaka et al., 1999). Thus, changes in systemic circulation could not be translated 
into a correspondent change in renal perfusion, at least in the aforementioned 
experimental studies.  
As mentioned earlier, an additional aim was to evaluate the role of ET-1 in the early 
inflammatory response in endotoxemia. Interleukin (IL)-6 is a cytokine produced by 
both inflammatory and non-inflammatory cells and its production is induced by acute 
inflammatory reactions such as sepsis. The release of IL-6 is stimulated by TNF-α and 
other pro-inflammatory cytokines and is therefore often used as a marker of 
proinflammatory cytokine activation. IL-6 has also been suggested as mediator of 
thrombosis in sepsis (Song & Kellum, 2005). Another cytokine IL-10 is on the other 
hand has anti-inflammatory properties and reduces the production of both IL-6 and 
TNF-α. It was described prior to the initiation of paper I, that ET-1 had inflammatory 
properties (Cunningham et al., 1997;Browatzki et al., 2000;Sasser et al., 2007), but in 
Paper I, tezosentan could not attenuate the plasma release of IL-6, IL-10, or TNF-α. 
The effects of tezosentan on renal perfusion, at least in this early phase of endotoxemia, 
appeared not to be mediated by interference with these cytokines. However, measuring 
plasma levels of these cytokines was not sufficient to rule out any changes in local 
production of these cytokines in the kidney.  
The clearance of ET-1 from the circulation had been suggested to mainly be mediated 
by ETB receptors and inhibition of ETB leads to increasing levels of ET-1 in the 
circulation (Fukuroda et al., 1994). This effect was demonstrated in paper I, and 
treatment with tezosentan resulted in a significantly higher arterial plasma level of ET-1 
compared with the control group. Since a close interaction between endothelin and the 
renin–angiotensin system had been described prior to this thesis, plasma levels of 
ANGII and aldosterone were examined in paper I. ET-1 had been shown to mediate 
some of the renal vasoconstriction and cardiovascular effects of angiotensin II 
(Alexander et al., 2001;Herizi et al., 1998). In addition, it was reported that ET-1 
stimulate the synthesis and release of aldosterone in the adrenal cortex , via both ETA 
and ETB receptors (Rossi et al., 2000). This made it reasonably to propose that 
tezosentan exerts some of its effects through the renin–angiotensin–aldosterone 
systems. This could, however, not be confirmed in paper I, at least not by changes in 
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plasma levels of aldosterone or ANG II between the groups. Given that ET-1 had been 
shown to contribute to some of the renal vasoconstrictor actions of ANG II (Riggleman 
et al., 2001). Reduced vasoconstrictor effect of ANGII in the renal circulation by 
tezosentan in endotoxemia could however not be ruled out.  
These results in Paper I showed that treatment with a dual ETA/ETB antagonist 
attenuated the acute reduction of renal perfusion in response to endotoxemia. A more 
preserved diuresis was expected as well. This was however not the fact, and a 
suggestion was that this was related to the ETB blockade by tezosentan as activation of 
ETB stimulates diuresis and natriuresis. Thus, a possible diuretic effect by the increase 
in renal blood flow could have been offset by the ETB inhibition. As the increase in 
plasma creatinine was significantly attenuated, a better preserved GFR by tezosentan 
could be suggested. However, urine production was very low, and no clearance 
measures were performed, which could have gained a more accurate estimation of GFR 
compared to merely measuring plasma creatinine. It was suggested that the effect of 
dual ETA/ETB-antagonism on cortical microcirculation seen in paper I were mainly 
mediated by the ETA inhibition. This made further study of selective ETA antagonism 
interesting, and paper II was initiated.  
ETA IN PORCINE ENDOTOXEMIA 
Paper II 
As mentioned before, ET-1 had been described to be a modulator of the renal 
microcirculation by constricting afferent and efferent arterioles mainly through 
activation of ETA (Denton et al., 2004). Furthermore, ET-1 had been shown to have 
tubular effects favoring diuresis and natriuresis described under normal physiological 
Figure 13. Changes in plasma 
levels of endothelin-1 in response 
to endotoxin infusion and 
subsequent tezosentan (1 
mg/kg/h) or control. Treatment 
was started at 2 hours of 
endotoxemia. Symbols show 
mean and SEM. *p<0.05 for the 
time–treatment interaction 
between 2 and 5 hours 
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conditions. The natriuretic effect of ET-1 was believed to be mediated through a 
reduction of Na/K ATPase activity in the collecting ducts (Zeidel et al., 1989) and 
through an inhibitory effect on the opening of epithelial Na channels in the collecting 
duct by ETB (Bugaj et al., 2008). The diuretic effect of ET-1 was suggested to 
primarily be due to the inhibition of arginine-vasopressin stimulated water permeability 
by activation of ETB (Edwards et al., 1993;Kohan et al., 2011). It was hypothesized in 
paper II that ET-1 mediates renal microcirculatory impairment in endotoxemia through 
activation of ETA and that treatment with TBC 3711, a highly selective ETA 
antagonist would improve renal microcirculation and function. The theoretical rationale 
for this was that the diuretic and vasodilatory effects of ETB would be preserved 
whereas the vasoconstrictive and pro-inflammatory properties of ETA would be 
inhibited. Pigs were subjected to LPS infusion for five hours and after two hours of 
endotoxemia they were treated with TBC 3711or served as endotoxin-treated controls. 
The main finding in paper II was that ET-1 reduced renal medullary perfusion due to 
activation of ETA-receptors. This medullary effect was independent of changes in renal 
artery blood flow, suggesting that the effect was mediated on a microcirculatory level. 
Furthermore, ETA-receptor antagonism also attenuated renal oxygen demand and the 
L/P-ratio measured in the renal cortex but had no significant effect on diuresis or 
creatinine clearance.  
As described in paper I, dual ETA/ETB antagonism attenuated the decline in renal 
artery blood flow and cortical microcirculation. This was not reproduced in paper II 
with selective ETA antagonism. There are several factors that could have influenced 
this difference in results between paper I and paper II. First, the effect on cardiac output 
by the ETA-antagonist in this study was less pronounced than the effect of tezosentan 
in the previous investigation. Second, in this normotensive model of endotoxemia, 
selective ETA antagonism caused hypotension. The reduced arterial pressure in the 
TBC 3711 group may have reached the lower limit of the autoregulatory range for RBF 
in pigs and influenced any effect by ETA antagonism on renal hemodynamics (Buckley 
et al., 1983). However, this hypotensive effect of ETA antagonism further indicates that 
the maintained medullary perfusion in the treatment group was not perfusion pressure-
dependent. Moreover, no difference in renal artery blood flow was detected between 
groups indicating that the effect of TBC 3711 was on a microcirculatory level in the 
medulla. This effect may have derived from redistribution of blood flow between 
juxtamedullary and cortical glomeruli, which could have lead to more perfusion of the 
medulla. Another alternative was redistribution towards pre-glomerular shunts.  
Hypoxia in the kidney is a matter of vigorous debate in the pathogenesis of septic acute 
kidney injury. In paper II, the early phase of endotoxemia renal oxygen delivery was 
increased, indicating that oxygen supply was not impaired at the onset of renal damage. 
Though renal artery blood flow was reduced by approximately 30%, oxygen delivery 
was maintained and a major reason for this was hemoconcentration. Endotoxemia often 
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results in a relative hypovolemia and reduced plasma volume. This leads to 
hemoconcentration and can be used as an indicator of hypovolemia. However, 
especially in pigs, hemoconcentration may be caused by extensive constriction of the 
spleen. This leads to increased amount of red blood cells in the system circulation, and 
spleen contraction have earlier been shown to contribute up to 20-25% of the red cell 
volume in pigs (Hannon et al., 1985).  
Reduced total renal oxygen demand was seen in the TBC 3711-treated group. As 
reabsorption of sodium is the most oxygen-demanding process in the kidney, changes 
in oxygen consumption may reflect a reduced work load of the tubules. However, no 
differences were seen in sodium excretion (estimated by FENa), renal artery blood flow 
or creatinine clearance. The control animals developed a more significant acidosis 
compared to TBC 3711-treated pigs and acidosis have been reported to influence renal 
oxygen handling (Evans et al., 2010).  Lower pH (or higher carbon dioxide) reduces the 
binding affinity of oxygen to hemoglobin (Bohr et al., 1904), and this will result in 
more oxygen being released in the kidney when metabolic demand increases. This 
effect was highlighted in a rat model (Chen et al., 2010), but the relative impact in the 
porcine kidney remains to be explored.  
The limitations of endogenous creatinine-clearance for determination of GFR may have 
influenced the results in paper II. When GFR is reduced, overestimation by creatinine-
clearance may occur in pigs due to the tubular secretion of creatinine. It could therefore 
not be ruled out that the reduced oxygen-consumption in the TBC 3711-treated group 
was a result of reduced GFR.   
Our hypothesis that selective ETA antagonism would improve diuresis by preserving 
ETB function was not supported by the findings in paper II. This might have been due 
to an inadequate observation period, but it may also suggest that the relative importance 
of using a specific ETA-antagonist for maintaining diuresis during endotoxemia is of 
limited use.  
Paper I and paper II of the first part of this thesis evaluated both selective ETA and dual 
ETA/ETB antagonism in porcine endotoxemia. First, the results from paper I confirmed 
previous investigations that mixed ETA/ETB antagonism with tezosentan may 
attenuate the decline in renal blood flow induced by endotoxemic shock. Second, 
selective ETA antagonism attenuated the decline in medullary blow flow in 
normotensive endotoxemia. However neither selective nor dual ETA/ETB antagonism 
could improve diuresis.  
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TLR4 IN OVINE ENDOTOXEMIA  
Paper III 
Study III was conducted to investigate the role of TLR4 in the development of LPS-
induced AKI in sheep. To do this, conscious animals were pre-treated with the selective 
TLR4 inhibitor TAK-242 or vehicle and subjected to 24 hours of endotoxemia during 
which renal function was monitored with measurements of creatinine clearance, urine 
output and plasma levels of BUN and creatinine. The main finding was that pre-
treatment with a TLR4-inhibitor reduced the renal dysfunction caused by endotoxemia. 
In order to explore if any effect of TAK-242 was due to preventing hypotension, a third 
group of LPS-treated animals receiving norepinephrine titrated to maintain baseline 
blood pressure was added. However, preserving MAP with norepinephrine and 
Figure 14. Changes in MAP (A), urine output (B)  creatinine clearance (C) and BUN in 
response to LPS-infusion and treatment with either the selective TLR4 antagonist, TAK-
242 (6 mg/24 hours, n=7) or  vehicle (n=7). Data are expressed as mean ± SEM. * 
indicates a significant difference between TAK-242 and vehicle in response to LPS.  †, 
indicates a significant difference between norepinephrine (NE) and vehicle in response to 
LPS. 
J. Fenhammar 
42 
additional fluid did not prevent the development of AKI. Thus, the renal protective 
effect of TLR4 inhibition was not dependent of prevention of hypotension. It was 
proposed that hypotension was of less importance for renal dysfunction in paper III. 
However, as no measurement of renal blood flow was performed in paper III, the 
question of any participation of renal hypoperfusion and ischemia warranted further 
research and renal hemodynamics was later investigated more thoroughly in paper IV.  
In paper III, TAK-242 did not reduce the fever-response to LPS. In earlier studies 
performed in rodents, TAK-242 had prevented some changes in body temperature (i.e. 
hypothermia). The lack of effect on body temperature could have been a consequence 
of incomplete inhibition of TLR4. The pharmacological TLR4 inhibitor that was used, 
TAK-242, binds directly to the amino acid Cys747 in the intracellular domain of the 
receptor (Takashima et al., 2009) and inhibits the activation of the downstream 
signaling pathway of the receptor (see figure 12 in the Materials and Methods section). 
Experiments to confirm the specificity of TAK-242 for TLR4 had been reported prior 
to paper II, mainly in rodents and humans. However, sheep TLR4 corresponds well to 
human TLR4 (Menzies & Ingham, 2006) but if this also reflects the same binding 
affinity for TAK-242 in not clear. Another proposed explanation for the remaining 
fever response was that the commercially LPS used in our studies was not perfectly 
pure and may contain pyrogens activating receptors other than TLR4.  
In paper III, TLR4 inhibition was administered prior to endotoxemia and the 
subsequent development of AKI. Several questions were generated after performing 
this study. First, paper III did not elucidate if TLR4 inhibition could reverse an already 
present AKI. Second, are changes in renal hemodynamics by TLR4 inhibition 
responsible for the beneficial effect on renal function? Third, is TLR4 inhibition 
effective if renal dysfunction were to be induced by live bacterial infection with a broad 
variety of pathogen patterns instead of a single toxin model such as LPS infusion? 
These questions urged further experiments, which were performed in paper IV. 
TLR4-INHIBITION AS A TREATMENT OF SEPTIC AKI  
Paper IV 
One of the main objectives of paper IV was to investigate if TLR4 inhibition is 
effective in attenuating or reversing renal dysfunction even after sepsis has developed. 
Therefore, TAK-242 was administered 12 hours after the onset of sepsis and the 
observation time was extended to 36 hours. Live E.coli infusion resulted in sepsis with 
a normotensive circulation for the entire experiment. To further explore the hypothesis 
that septic AKI was due to regional blood flow restriction, total renal blood flow as 
well as cortical and medullary microcirculation was measured.  
The laser doppler technique had previously been used in both paper I and II, but the use 
in conscious animals added some complexity. Optical fibers chronically implanted in 
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conscious rats for detection of renal cortical and medullary blood flow changes by 
laser-doppler flowmetry had previously been used and validated in chronic studies 
(Mattson et al., 1994;Lu et al., 1993). However, in paper IV the experiments started 12-
18 hours after the probes were surgically implanted. This was a limitation, and may 
have influenced the result. To address this issue a sham-experiment was performed 
with a sheep subjected to surgery and the following protocol without treatment or 
sepsis. However, a chronic implantation of laser doppler probes with a following 
recovery period of several weeks is indeed an alternative that is of great interest for 
further investigations.  
The renal histopathology was not clear in septic AKI and studies investigating 
structural damage to the kidney in long-term animal model of sepsis were sparse,  
(Langenberg et al., 2008). In paper IV, both light and electron microscopy were used to 
analyze renal samples taken at the end of the 36 hour study period with regards to 
possible morphological changes causing the renal dysfunction. An additional objective 
to this study was to explore potential local immunological pathways causing septic 
AKI. In order to do this, histological sections were stained for infiltrating leukocytes. 
Anti-myeloperoxidase antibodies were used to stain leukocytes and helped the 
investigator to identify neutrophils.  
The main finding in paper IV was that TAK-242 reversed a progressive decline in renal 
function when administered therapeutically after 12 hours of hyperdynamic E.coli 
sepsis. This was associated with a reduction in renal neutrophil infiltration as well as an 
attenuation of arterial and renal hyperlactemia. Signs of decreased swelling in the 
endothelium of the glomerular capillaries were also observed. In addition to this, no 
major effects on systemic or local renal hemodynamics by TAK-242 were seen. As this 
ovine model of sepsis, resulted in a normotensive circulation combined with severe 
renal dysfunction, it was suggested that hypotension was not a necessary attribute for 
septic AKI. This was in line with earlier studies in critically ill patients with severe 
sepsis, where blood pressure levels did not correlate with the severity of AKI (Chawla 
et al., 2007). Previous investigations had shown that experimental septic AKI 
developed although total renal blood flow was increased (Langenberg et al., 
2006b;Frithiof et al., 2011) and  when hypotension was counteracted by fluid and 
norepinephrine (paper III). The findings in this thesis (paper I, II and IV) show 
diversity in the renal blood flow response to endotoxemia and sepsis, but they are not 
the only ones reporting contradictory results in this matter. Findings on renal blood 
flow in experimental sepsis have been reviewed by Langenberg and coworkers. Their 
systematic review of 159 experimental studies showed that 99 studies reported 
decreased RBF whereas 60 reported unchanged or increased renal perfusion 
(Langenberg et al., 2005). They also tried to investigate variables that could influence 
RBF in these studies. Several variables were chosen including animal size, small 
animals (rats, mice, rabbits and piglets) versus large animals (dogs, pigs and sheep). 
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Technique for measuring RBF, direct measurement of RBF (ultrasonic or 
electromagnetic flow probes) was compared to indirect measurement (microspheres, 
para-aminohippurate (PAH), video microscopy). Other investigated variables were 
recovery period between surgical preparation and actual experiment, duration of sepsis, 
animal model of sepsis (e.g. LPS, live bacteria and CLP), fluid resuscitation, 
consciousness of animals and cardiac output. They concluded that the available 
experimental data was extraordinarily heterogeneous. The sole variable that was 
significant after a multivariate logistic analysis was cardiac output (CO). Low CO 
predicted a decrease in RBF and an increased or preserved CO predicted increased or 
preserved RBF (Langenberg et al., 2005). In view of the papers included in this thesis, 
data show both decreased (paper I and II) and increased renal artery blood flow (paper 
IV). Indeed a difference in cardiac output between the different papers was found, but if 
other variables, such as consciousness also may have influenced renal blood flow 
response is not clear. With regards to the effects of TAK-242, no major effects on 
systemic or local renal hemodynamics by were seen in paper IV. 
Regarding measurements of metabolism in paper IV, both cortical and medullary L/P 
ratios were significantly increased by sepsis but subsequently reduced by TAK-242. In 
view of the preserved renal circulation the renal hyperlactemia cannot easily be 
explained by reduced renal oxygen supply. Though, as mentioned before, one of the 
limitations of the laser doppler technique is that heterogeneity in the renal 
microcirculation cannot be detected. In addition, direct measurement of renal tissue 
oxygenation or the utilization of oxygen by renal mitochondria was not performed in 
our study. In both paper II and IV renal hyperlactemia developed as a result of 
experimental sepsis. However, hyperlactemia is not only an indicator of ischemia in 
sepsis. Aerobic glycolysis, liver failure, decreased pyruvate dehydrogenas function, 
elevated catecholamine concentrations and mitochondrial dysfunction have all been 
suggested to participate in septic hyperlactemia (Venkatesh et al., 2010). It is proposed 
that, when cells are subjected to ischemia the hydrolysis of ATP will generate an 
accumulation of hydrogen ions in the cytosol of the cells. This will result in increased 
acidosis. However, under aerobic conditions the hydrogen ions produced by hydrolysis 
of ATP will be used in the metabolism of glucose. The later reaction will therefore not 
result in a net acidosis. During sepsis both anaerobic and aerobic metabolism may 
occur simultaneously, but the relative importance of each metabolic pathway is difficult 
to estimate. In other non-renal tissue, such as muscle, lactate may be produced under 
aerobic conditions in a process linking glycolytic ATP supply to stimulation of 
Na/KATPase (Levy et al., 2005). Opposite to muscle, the kidney is, under normal 
conditions, important in the removal of lactate from the circulation (Bellomo, 2002). 
This is performed by glucose production and account for a large amount of the glucose 
created in sheep renal gluconeogenesis (Kaufman & Bergman, 1974). Sepsis reduces 
the capacity of this renal process, contributing to excessive levels of lactate (Ardawi et 
al., 1990). Based on the data in paper IV it may be postulated that sepsis diminished 
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lactate removal by the kidney, and that TAK-242 inhibited this effect. Lower lactate 
levels within the kidney in paper IV, as compared to arterial levels, further support the 
concept of the kidney as a consumer rather than a net producer of lactate. The renal 
hyperlactemia seen in paper IV may be a reflection of systemic hyperlactemia rather 
than a sign of renal ischemia. The lactate that reaches the kidney from the systemic 
circulation is freely filtered in the glomerulus and reabsorbed in the proximal tubule 
(Barac-Nieto et al., 1980). Therefore, the renal interstitial lactate levels in paper IV may 
presumably reflect production of both renal lactate and that of systemic origin.  
With regards to other variables than merely hemodynamics, reduced TLR4-dependent 
infiltration of polymorphonuclear leukocytes (PMN) may have contributed to the 
improved renal function in the TAK-242 group of paper IV. Immunohistochemistry 
was performed on renal biopsies and revealed that TAK-242 treatment significantly 
reduced the number of PMNs in both the glomeruli and the interstitium. The 
endothelium is essential in maintaining vascular integrity but also important in the 
onset and preservation inflammation. Activation of renal endothelial TLR4 has been 
suggested to play a critical role in the up-regulation of adhesion molecules which can 
Figure 15. Immunohistochemistry of polymorphonuclear leukocytes (PMN) in sections with 
anti-myeloperoxidase antibodies show increased number of PMN in glomerular capillaries 
(G) and interstitium/peritubular capillaries (arrow) in vehicle (A) and TAK-242 treated group 
(B) in comparison to sham (C). Number of PMN in glomerulus and interstitium in vehicle and 
TAK-242 treated group (D). Data are expressed as mean and SD. * indicates a significant 
difference between TAK-242 and control in response to sepsis. 
BA 
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promote the recruitment of leukocytes to areas of injury and aggravate damage and 
inflammation in the tissue (Andonegui et al., 2003;Chen et al., 2011). A study that 
examined renal biopsies taken immediately after death in 19 patients dying of septic 
shock with anuric AKI and these biopsies were compared with nine patients without 
septic shock or AKI and to eight trauma victims. This study showed intense infiltration 
of leucocytes in glomeruli and interstitial capillaries and apoptosis of tubular cells and 
glomerular cells did also occur (Lerolle et al., 2010). Our histological findings in paper 
IV display several similarities, increased infiltration of PMN in both glomerulus and 
interstitium, limited signs of tubular injury and thrombi formation only in a few 
biopsies. The study in septic patients from Lerolle et al suggested that acute tubular 
necrosis may not be the main mechanism for septic AKI, other mechanism such as 
renal inflammation and apoptosis may large contributors to septic renal dysfunction. 
In paper IV, examination of the glomerulus with electron microscopy could not detect 
any difference in the degree of foot process effacement, which is a sign of podocyte 
injury displayed as retraction, widening, and shortening of the processes of each 
podocyte. The thickness of the glomerular basement membrane between the vehicle- 
and TAK-242-treated groups displayed no differences. However, there was a difference 
in the ultrastructure of the endothelial cells in the glomerular capillaries. In general, the 
endothelial cells of the vehicle-treated animals were swollen and showed decreased 
fenestration compared to TAK-242-treated animals. Although these electron 
microscopy findings need further investigation, a TLR4-dependent pathway causing 
renal inflammation and severe renal impairment in sepsis is an exciting possibility.  
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CONCLUSIONS 
 
Based on the experiments performed in this thesis the following conclusions were 
made:  
 
• Neither hypotension nor renal hypoperfusion is mandatory for the development 
of septic renal failure  
• Activation of TLR4 may contribute to the development of renal failure in ovine 
sepsis, but not by affecting systemic or renal hemodynamics 
• Treatment with a TLR4-inhibitor effectively restores renal function in ovine 
sepsis 
• Endothelin-1 contributes to renal vasoconstriction in hypodynamic porcine 
endotoxemic shock  
• Activation of ETA by endothelin-1 reduces renal medullary blood flow causing 
ischemia but does not acutely impair kidney function in normotensive porcine 
endotoxemia  
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